Track market-moving stories before they get noisy

GE HealthCare's MINItrace™ Magni achieves CE Mark; Copper-64 expands PETtrace™ Solid Target Platform beyond Gallium-68 GE HealthCare (Nasdaq: GEHC) today announced that its MINItrace Magni cyclotron has achieved CE Mark and that its PETtrace Solid Target Platform is expanding beyond Gallium-68 with support for Copper-64 (⁶⁴Cu) production. Together, the developments reflect the company’s focus on helping institutions build the production capabilities behind their molecular imaging programs—from establishing local PET radioisotope production to supporting research into emerging radiopharmaceuticals.

For healthcare providers building or expanding a positron emission tomography (PET) program, access to tracers is an important consideration. Many PET radioisotopes have short half-lives, making proximity between production and use a factor in supply planning. Cyclotrons produce these radioisotopes, which can then be incorporated into radiotracers used in PET imaging. Local production can give providers greater control over supply and scheduling while reducing reliance on external production and transportation.

“The molecular imaging landscape is being reshaped by the expansion of theranostics, the introduction of new PET tracers, and demand across oncology, neurology and cardiology,” said Erez Levy, Vice President of Molecular Imaging at GE HealthCare. “As tracer portfolios broaden, healthcare providers need reliable access to radioisotopes and the flexibility to respond to changing clinical needs. That calls for a longer-term view of radiopharmaceutical production—one that supports established services while allowing institutions to prepare for new clinical and research applications.”

MINItrace™ Magni: supporting local production through compact design and automation
For institutions seeking to establish or expand in-house production, MINItrace Magni brings together a compact, self-shielded design and simplified operation. The cyclotron is designed to produce Fluorine-18 (¹⁸F), Carbon-11 (¹¹C), Oxygen-15 (¹⁵O) and Nitrogen-13 (¹³N) for PET tracers. Its CE Mark represents an important milestone for a system designed around the needs of in-house PET radioisotope production.

Aiming to help extend day-to-day operations, MINItrace Magni features an intuitive user interface and a three-click workflow designed to streamline routine production steps. Automated features are intended to simplify setup and operation, including auto-tuning, which prepares the cyclotron and targets, tunes the beam and manages target irradiation.

Producing the radioisotope is only one part of preparing a PET tracer. When used with GE HealthCare’s TRACERcenter Solutions, MINItrace Magni is designed to support a broader PET radiopharmacy workflow based on an institution’s clinical, operational and tracer-production needs. This approach supports providers in developing tailored local radiopharmaceutical capabilities aligned to the specific requirements of their molecular imaging programs, while considering both current and future departmental needs to create a sustainable holistic solution.

Copper-64: broadening the possibilities for PETtrace production
Alongside decisions about where to produce radioisotopes, institutions must consider which radioisotopes their programs will need. For those seeking to broaden their production capabilities, the addition of Copper-64 extends the PETtrace Solid Target Platform beyond the production of Gallium-68, for which it was introduced in 2022, and Zirconium-89, which was made available in early 2026. The capability broadens the range of isotopes that may be produced using PETtrace cyclotron infrastructure, allowing customers to build on the platform as their isotope needs evolve.

Copper-64’s relevance includes exploring its potential role in connecting imaging with investigational therapeutic applications. It enables PET imaging and is also being studied with investigational Copper-67 agents as a potential diagnostic and therapeutic pair. This research sits within the broader field of theranostics, which connects molecular imaging with targeted radionuclide therapy. Clinical research is evaluating Copper-64-labeled compounds in areas including prostate cancer and HER2-positive breast cancer.

Supporting that work involves more than the cyclotron alone. GE HealthCare’s capabilities in cyclotrons, targetry, radiochemistry synthesis, molecular imaging and services are intended to help institutions establish solid-target production as part of a broader radiopharmacy workflow.

“A molecular imaging program needs a plan for the tracers it uses today and the ones it may want to explore tomorrow,” said Nicolas Durand-Schaefer, General Manager, Molecular Imaging, International, GE HealthCare. “MINItrace Magni’s CE Mark is an important milestone for a compact, versatile cyclotron designed to support local radioisotope production and enable healthcare providers to build radiopharmacy capabilities without the need for large-scale production infrastructure. Adding Copper-64 to PETtrace broadens the platform’s capabilities to support copper-based imaging and theranostics research. Our focus is on helping institutions connect the practical demands of running a radiopharmacy with their longer-term clinical and research ambitions.”

Both developments build on more than 40 years of GE HealthCare experience in cyclotron and PET radiopharmacy technologies, extending the company’s focus on the production capabilities and workflows that support molecular imaging.

For more information about GE HealthCare’s PET radiopharmacy solutions, visit gehealthcare.com or meet with company representatives in the GE HealthCare booth at the European Association of Nuclear Medicine’s 2026 Annual Meeting, October 17-21 in Vienna, Austria.

About GE HealthCare Technologies Inc.
GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Advanced Imaging Solutions, Pharmaceutical Diagnostics, and Patient Care Solutions segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.

GE HealthCare is proud to be among 2026 Fortune World’s Most Admired Companies™.

Follow us on LinkedIn, Facebook, Instagram, or visit our website for our latest news and perspectives.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261015750771/en/

Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.

Click for the complete disclosure

First Citizens Bank & Trust Co. bought a new position in shares of DoorDash, Inc. (NASDAQ:DASH – Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 32,279 shares of the company’s stock, valued at approximately $5,925,000.

A number of other hedge funds also recently added to or reduced their stakes in DASH. Krilogy Financial LLC grew its stake in DoorDash by 407.0% during the 3rd quarter. Krilogy Financial LLC now owns 7,945 shares of the company’s stock worth $1,458,000 after purchasing an additional 6,378 shares in the last quarter. NorthCrest Asset Manangement LLC purchased a new stake in DoorDash during the 3rd quarter worth about $1,354,000. Eastern Bank purchased a new stake in DoorDash during the 3rd quarter worth about $69,000. QRG Capital Management Inc. raised its position in DoorDash by 191.2% in the 2nd quarter. QRG Capital Management Inc. now owns 251,374 shares of the company’s stock valued at $46,386,000 after purchasing an additional 165,039 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. raised its position in DoorDash by 501.7% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 29,211 shares of the company’s stock valued at $5,390,000 after purchasing an additional 24,356 shares in the last quarter. 90.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes Several equities analysts have recently issued reports on the company. Argus lifted their price objective on DoorDash from $190.00 to $270.00 in a research note on Thursday, August 27th. UBS Group reissued a “buy” rating and set a $295.00 price objective on shares of DoorDash in a research report on Tuesday, September 8th. TD Cowen upped their target price on shares of DoorDash from $225.00 to $240.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Scotiabank initiated coverage on shares of DoorDash in a report on Wednesday, September 9th. They issued a “sector outperform” rating and a $275.00 target price on the stock. Finally, Barclays cut shares of DoorDash from an “equal weight” rating to a “strong sell” rating in a report on Monday, August 24th. Two investment analysts have rated the stock with a Strong Buy rating, thirty-one have given a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, DoorDash presently has an average rating of “Moderate Buy” and an average price target of $254.95.

Check Out Our Latest Report on DASH Insider Buying and Selling at DoorDash In other news, CEO Tony Xu sold 29,567 shares of the firm’s stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $230.00, for a total transaction of $6,800,410.00. Following the sale, the chief executive officer owned 1,500 shares of the company’s stock, valued at approximately $345,000. This trade represents a 95.17% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Ravi Inukonda sold 19,505 shares of the firm’s stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $220.62, for a total value of $4,303,193.10. Following the sale, the chief financial officer directly owned 232,938 shares in the company, valued at $51,390,781.56. This trade represents a 7.73% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 393,998 shares of company stock worth $85,861,330. Corporate insiders own 44.90% of the company’s stock.

DoorDash Stock Performance Shares of DASH stock opened at $184.01 on Thursday. The company has a market cap of $79.73 billion, a P/E ratio of 96.34 and a beta of 1.90. The firm has a fifty day moving average price of $205.78 and a 200 day moving average price of $183.57. The company has a current ratio of 1.37, a quick ratio of 1.37 and a debt-to-equity ratio of 0.27. DoorDash, Inc. has a 12 month low of $143.30 and a 12 month high of $285.50.

DoorDash (NASDAQ:DASH – Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $0.46 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.01). DoorDash had a net margin of 5.29% and a return on equity of 8.48%. The business had revenue of $4.45 billion during the quarter, compared to analyst estimates of $4.34 billion. During the same quarter in the prior year, the business earned $0.65 earnings per share. The firm’s quarterly revenue was up 35.6% on a year-over-year basis. Sell-side analysts predict that DoorDash, Inc. will post 2.51 earnings per share for the current fiscal year.

Key DoorDash News Here are the key news stories impacting DoorDash this week:

Positive Sentiment: DoorDash is partnering with Woolworths Group to bring BIG W to its Australian marketplace, offering more than 35,000 everyday products with delivery in as little as 60 minutes. The agreement expands DoorDash’s retail selection and supports its strategy of increasing order frequency beyond restaurant delivery. BIG W Lands on DoorDash App Positive Sentiment: DoorDash launched an on-demand delivery collaboration with SKIMS, giving customers access to apparel and related products. The partnership, supported by Kim Kardashian-focused marketing, could improve consumer awareness of DoorDash’s non-food offerings. SKIMS and DoorDash Partnership Positive Sentiment: DoorDash is expanding into Geraldton, Kalgoorlie and Horsham in Australia, indicating continued investment in regional coverage and potential long-term marketplace growth. DoorDash Regional Australian Expansion About DoorDash (Free Report)

DoorDash, Inc is a technology company that operates a local commerce platform connecting consumers with restaurants, grocery stores, convenience retailers and other merchants. Through its DoorDash app and website, customers can discover businesses, place orders for delivery or pickup, and access related services. The company also provides merchants with tools for online ordering, logistics, customer engagement, advertising and business analytics.

DoorDash generates additional activity through subscription programs such as DashPass, which provides participating customers with delivery-related benefits, and through its logistics and commerce solutions for merchants.

Featured Stories Five stocks we like better than DoorDash Tesla Wants to Make Its Own Chips—What Could Go Wrong? IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver? PBF Energy’s Stunning Rally Faces a Critical Test Citi Stock Falls Despite Earnings Beat: What Investors Need to Know

Receive News & Ratings for DoorDash Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DoorDash and related companies with MarketBeat.com's FREE daily email newsletter.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators presented new data showing the critical role of blood-based testing in increasing overall colorectal cancer (CRC) screening and follow-up colonoscopy adherence at the American College of Gastroenterology (ACG) 2026 Annual Meeting in Nashville, Tennessee.

A modeling study looking at individuals 45 to 75 over a lifetime projected the health outcomes of blood-based testing compared to other non-invasive tests using real-world evidence for follow-up colonoscopy adherence, showing that blood-based screening may increase rather than lower the need for colonoscopy by bringing more patients into the screening pathway. With longitudinal test adherence and real-world follow-up colonoscopy adherence (FU-CY), blood-based screening increased the number of colonoscopies (679 vs. 113 and 326) and also averted more CRC deaths (12 vs. 6 and 9) compared to FIT and mt-sDNA testing per 1,000 simulated individuals during their lifetime.

Building off findings from Guardant Health’s 2025 study in Appalachia, another key study looked at clinical implementation of Shield in two rural health clinics in South Carolina which demonstrated a 99% real-world adherence rate, well above average screening adherence for overall CRC testing which ranges from 28-71%12. The notable findings reiterate the impact of blood-based tests in increasing CRC screening participation and improving outcomes, particularly for medically-underserved communities.

“Today’s research continues to reinforce the data we’ve seen across Guardant’s robust real-world evidence: blood-based screening meaningfully closes gaps in colorectal cancer screening participation with a significant lift in underserved communities that face some of the most persistent access barriers,” said Sam Asgarian, Guardant Health's VP of Clinical Affairs. “For the first time, we’ve been able to correlate the impact of real-world follow-up colonoscopies and screening adherence with the modeling studies of the Shield blood test. We're proud to present this compelling research with our collaborators at ACG and to continue to demonstrate Shield’s role as a clinically meaningful alternative to traditional screening methods.”

Shield was purpose-built to close screening gaps in population health, as the most-clinically validated blood test in market and the first blood test to receive FDA approval as a primary screening option for CRC in average-risk adults 45 and older. With more than 200,000 tests performed in real-world settings, Shield is proven to significantly increase overall CRC screening completion for patients due for CRC screening across practice and health system settings, demonstrating over 90% screening adherence.3

The full abstracts for Guardant Health and a list of all abstracts presented at the ACG Annual Meeting can be found here.

About Shield

Shield is a methylation partitioning cell-free DNA (mp-cfDNA) non-invasive, blood-based screening test that detects alterations associated with colorectal cancer in the blood. It is intended as a screening test for individuals at average risk for the disease, age 45 or older, and is not intended for individuals at high risk for colorectal cancer. The Shield test can be considered in a manner similar to guideline-recommended non-invasive CRC screening options and can be completed during any healthcare visit. A positive Shield result raises concern for the presence of colorectal cancer or advanced adenoma and the patient should be referred for colonoscopy evaluation.

About Guardant Health

Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.

Guardant Health Forward-Looking Statements

This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding the potential utilities, values, benefits and advantages of Guardant Health’s liquid biopsy tests or assays, which involve risks and uncertainties that could cause the actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are based on current expectations, forecasts and assumptions, and actual outcomes and results could differ materially from these statements due to a number of factors. These and additional risks and uncertainties that could affect Guardant Health’s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operation” and elsewhere in its Annual Report on Form 10-K for the year ended December 31, 2025 and in its other reports filed with or furnished to the Securities and Exchange Commission. The forward-looking statements in this press release are based on information available to Guardant Health as of the date hereof, and Guardant Health disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing Guardant Health’s views as of any date subsequent to the date of this press release.

1 Gellad ZF, Stechuchak KM, Fisher DA, et al. Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. Am J Gastroenterol. 2011;106(6):1125-1134.
2 Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172(7):575-582.
3 Graham-Adderton C, Guerra CE, Ngo-Metzger Q, Hoang T, Raymond VM. Implementation of blood-based colorectal cancer screening: real-world adherence and outcomes. Curr Med Res Opin. 2025;41(10):1915-1920. doi:10.1080/03007995.2025.2582257

View source version on businesswire.com: https://www.businesswire.com/news/home/20261015639865/en/

Elemental Capital Partners LLC boosted its stake in Credo Technology Group Holding Ltd. (NASDAQ:CRDO – Free Report) by 1.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 237,658 shares of the company’s stock after purchasing an additional 4,520 shares during the quarter. Credo Technology Group comprises about 11.2% of Elemental Capital Partners LLC’s holdings, making the stock its 2nd biggest position. Elemental Capital Partners LLC owned 0.13% of Credo Technology Group worth $46,293,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. GAMMA Investing LLC increased its stake in Credo Technology Group by 2.6% during the 3rd quarter. GAMMA Investing LLC now owns 1,986 shares of the company’s stock valued at $387,000 after purchasing an additional 51 shares in the last quarter. City Center Advisors LLC lifted its stake in shares of Credo Technology Group by 2.1% in the second quarter. City Center Advisors LLC now owns 2,595 shares of the company’s stock valued at $706,000 after buying an additional 53 shares in the last quarter. Versant Capital Management Inc grew its holdings in shares of Credo Technology Group by 8.0% during the second quarter. Versant Capital Management Inc now owns 755 shares of the company’s stock valued at $205,000 after buying an additional 56 shares during the last quarter. QRG Capital Management Inc. grew its holdings in shares of Credo Technology Group by 1.7% during the first quarter. QRG Capital Management Inc. now owns 5,402 shares of the company’s stock valued at $507,000 after buying an additional 91 shares during the last quarter. Finally, Krilogy Financial LLC grew its holdings in shares of Credo Technology Group by 8.7% during the third quarter. Krilogy Financial LLC now owns 1,136 shares of the company’s stock valued at $228,000 after buying an additional 91 shares during the last quarter. 80.46% of the stock is owned by institutional investors.

Insider Buying and Selling at Credo Technology Group
In other Credo Technology Group news, CTO Chi Cheng sold 27,500 shares of Credo Technology Group stock in a transaction that occurred on Wednesday, September 23rd. The shares were sold at an average price of $193.12, for a total transaction of $5,310,800.00. Following the completion of the sale, the chief technology officer directly owned 5,689,897 shares in the company, valued at $1,098,832,908.64. The trade was a 0.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Yat Lam sold 55,441 shares of the business’s stock in a transaction that occurred on Friday, July 31st. The stock was sold at an average price of $213.02, for a total transaction of $11,810,041.82. Following the completion of the transaction, the chief operating officer directly owned 2,529,169 shares of the company’s stock, valued at approximately $538,763,580.38. This represents a 2.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 468,786 shares of company stock worth $95,025,003. Insiders own 9.06% of the company’s stock.

Analysts Set New Price Targets
Several analysts have recently commented on the company. Mizuho lowered their price objective on Credo Technology Group from $290.00 to $245.00 and set an “outperform” rating for the company in a research note on Monday, September 21st. Bank of America dropped their target price on Credo Technology Group from $340.00 to $275.00 and set a “buy” rating on the stock in a report on Wednesday, September 2nd. Rosenblatt Securities lifted their target price on Credo Technology Group from $215.00 to $235.00 and gave the company a “neutral” rating in a research report on Wednesday, September 2nd. Zacks Research cut Credo Technology Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 3rd. Finally, Weiss Ratings downgraded Credo Technology Group from a “hold (c+)” rating to a “hold (c)” rating in a report on Tuesday, October 6th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $262.67.
Read Our Latest Stock Analysis on CRDO

Credo Technology Group News Roundup
Here are the key news stories impacting Credo Technology Group this week:

Positive Sentiment: Credo’s latest outlook remains robust, with revenue expected at approximately $525 million to $535 million and fiscal 2027 revenue projected to increase by more than 85%. The company’s most recent quarter delivered 114.7% year-over-year revenue growth to $479 million, exceeding analyst expectations. Credo revenue outlook article
Positive Sentiment: The company introduced its 1.6T ZeroFlap Active Light Cable for AI data centers. The product is designed to provide longer reach, lower power consumption and improved reliability, potentially expanding Credo’s addressable market as hyperscalers increase networking capacity. Credo ZeroFlap cable article
Positive Sentiment: Credo is helping lead an Open Compute Project workstream to standardize short-reach micro-emitter optics. If approved and adopted, the effort could support future optical connectivity sales and help reduce the company’s reliance on a small number of major customers. Credo SRMO workstream article
Neutral Sentiment: Analysts remain broadly optimistic, with a consensus “Moderate Buy” rating, but several firms have recently reduced price targets. The stock’s premium valuation and dependence on two large customers leave limited room for execution setbacks. Credo valuation and customer concentration article
Negative Sentiment: CRDO declined alongside AI infrastructure peers, including Astera Labs, in what appears to be sector-wide profit-taking rather than a newly reported deterioration in Credo’s operations. The decline highlights the stock’s elevated volatility and sensitivity to AI spending sentiment. Credo stock decline analysis
Negative Sentiment: CTO Chi Cheng sold 31,290 shares, while CFO Daniel Fleming previously sold 7,580 shares; both transactions were conducted under pre-arranged Rule 10b5-1 plans. The sales were modest relative to their remaining holdings but may still weigh on sentiment.

Credo Technology Group Price Performance
Shares of CRDO opened at $179.23 on Thursday. The firm has a market cap of $33.69 billion, a PE ratio of 67.00, a PEG ratio of 0.79 and a beta of 3.25. The stock’s fifty day moving average price is $207.08 and its two-hundred day moving average price is $204.49. Credo Technology Group Holding Ltd. has a 1 year low of $86.49 and a 1 year high of $308.67.

Credo Technology Group (NASDAQ:CRDO – Get Free Report) last issued its quarterly earnings data on Tuesday, September 1st. The company reported $1.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.03. Credo Technology Group had a return on equity of 28.77% and a net margin of 33.83%. The business had revenue of $479.00 million for the quarter, compared to analysts’ expectations of $473.30 million. During the same quarter in the prior year, the firm posted $0.52 EPS. The firm’s quarterly revenue was up 114.7% on a year-over-year basis. Sell-side analysts anticipate that Credo Technology Group Holding Ltd. will post 5.02 earnings per share for the current fiscal year.

(Free Report)

Credo Technology Group Holding Ltd. develops high-speed connectivity solutions for data infrastructure. Its technologies are designed to improve the performance, power efficiency and reliability of connections used in cloud computing, artificial intelligence, high-performance computing, telecommunications and enterprise networks.

The company’s product portfolio includes serializer/deserializer (SerDes) intellectual property, integrated circuits, active electrical cables and optical connectivity products.

Further Reading

Five stocks we like better than Credo Technology Group
Tesla Wants to Make Its Own Chips—What Could Go Wrong?
IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
PBF Energy’s Stunning Rally Faces a Critical Test
Citi Stock Falls Despite Earnings Beat: What Investors Need to Know

Want to see what other hedge funds are holding CRDO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Credo Technology Group Holding Ltd. (NASDAQ:CRDO – Free Report).

Receive News & Ratings for Credo Technology Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Credo Technology Group and related companies with MarketBeat.com's FREE daily email newsletter.

Recommendation based on results from Phase 3 RASolute 302 trial, which demonstrated a 60% reduction in risk of death compared with chemotherapy in the overall study population with statistically significant and clinically meaningful improvements across all primary and key secondary endpoints, regardless of tumor RAS mutation statusPositive CHMP opinion follows an expedited phased review of RASONQUE under the EMA’s Cancer Medicines Pathfinder project based on its potential to address a high unmet medical need REDWOOD CITY, Calif., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a global, commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion of RASONQUE (daraxonrasib) once-daily oral tablets as a monotherapy indicated for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy. If approved by the European Commission (EC), RASONQUE would provide the first broad RAS-targeted treatment option in the European Union for adults with metastatic pancreatic adenocarcinoma.

“Today’s positive CHMP opinion marks a major step toward making RASONQUE available to eligible adults with metastatic pancreatic cancer in the European Union,” said Mark A. Goldsmith, M.D., Ph.D., chief executive officer and chairman of Revolution Medicines. “RASONQUE is an oral medicine designed to address RAS, the key driver of pancreatic cancer, and unprecedented results from the Phase 3 RASolute 302 trial demonstrated its potential to benefit patients with this devastating disease. Its expedited review under the EMA’s Cancer Medicines Pathfinder project highlights how innovative regulatory pathways may help bring promising medicines to patients sooner. We look forward to the EC’s consideration of this CHMP positive opinion as we continue to work with regulatory authorities around the world to pursue additional approvals and broaden access to RASONQUE.”

RASolute 302: Phase 3 Clinical Trial Results Supporting Positive CHMP Opinion

The positive CHMP opinion is based on results from RASolute 302, a global, randomized Phase 3 trial evaluating RASONQUE versus investigator’s choice of cytotoxic chemotherapy in patients with previously treated metastatic PDAC. The trial met all primary and key secondary endpoints in both the RAS G12 mutant population and the overall intent-to-treat (ITT) population, which included patients with or without an identified tumor RAS mutation.

The primary analysis from RASolute 302 was presented at the 2026 American Society of Clinical Oncology Annual Meeting with simultaneous publication in The New England Journal of Medicine. In the ITT population, RASONQUE reduced the risk of death by 60% compared with chemotherapy, with a hazard ratio (HR) of 0.40 (95% confidence interval [CI]: 0.30–0.53; p<0.0001). The median overall survival (OS) was 13.2 months (95% CI: 10.0–NE) with RASONQUE compared to 6.7 months (95% CI: 5.8–8.0) for chemotherapy. RASONQUE also showed significant improvements in progression-free survival (PFS) with an HR of 0.49 (95% CI: 0.38–0.64; p<0.0001). The median PFS was 7.2 months (95% CI: 5.7–7.5) with RASONQUE compared to 3.6 months (95% CI: 2.9–4.2) with chemotherapy. Results were generally consistent in the RAS G12 population. A subsequent ad hoc OS analysis showed the median OS was 12.4 months with RASONQUE compared to 6.7 months for chemotherapy [HR: 0.49 (95% CI 0.39, 0.62)], which was generally consistent with the prespecified primary analysis.

The most common adverse reactions in patients treated with RASONQUE were diarrhea (63.1%), dermatitis acneiform (62.4%), stomatitis (55.5%), nausea (50.8%), vomiting (41.6%) and fatigue (33.2%).

Once granted by the EC, the centralized marketing authorization will be valid in all EU member states, as well as in the European Economic Area (EEA) countries Iceland, Norway and Liechtenstein; marketing authorization by the EC is not applicable in the United Kingdom or Switzerland, which have separate processes for considering new drug applications.

This CHMP Positive Opinion follows the approval of RASONQUE by U.S. Food and Drug Administration (FDA) on August 26, 2026.

About Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma, or PDAC, is the most common form of pancreatic cancer and among the most lethal malignancies, frequently with a late diagnosis, aggressive biology, and limited responsiveness to available treatments. RAS, a key growth control switch in human cells, is the main driver of pancreatic cancer, which is characterized by excessive RAS signaling. Approximately 147,000 people are diagnosed with pancreatic cancer in Europe each year, and the five-year survival rate remains below 10%.1,2 Because early-stage pancreatic cancer often causes few or no symptoms, approximately 80% of patients are diagnosed after the disease has spread, when treatment options are more limited.3

About RASONQUETM (daraxonrasib)

RASONQUE (daraxonrasib) is an oral, RAS(ON) multi-selective, noncovalent, tri-complex inhibitor (TCI), approved by the U.S. FDA for the treatment of adult patients with metastatic PDAC who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy.4 RASONQUE is being investigated through a global Phase 3 registrational program in patients with PDAC and metastatic RAS mutant non-small cell lung cancer (NSCLC).

Outside the U.S., RASONQUE is an investigational agent that has not been approved by any regulatory authority. RASONQUE received orphan medicinal product designation for pancreatic cancer and high-priority status under EMA’s Cancer Medicines Pathfinder project based on its potential to address a significant unmet need.

U.S. INDICATION

RASONQUE is indicated for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy.

U.S. IMPORTANT SAFETY INFORMATION

RASONQUE is associated with the following Warnings and Precautions: Dermatologic and Soft Tissue Toxicity, Stomatitis and Oral Disorders, Diarrhea, Gastrointestinal Perforation, Interstitial Lung Disease (ILD)/Pneumonitis, and Embryo-Fetal Toxicity.

U.S. WARNINGS AND PRECAUTIONS

Dermatologic and Soft Tissue Toxicity

RASONQUE can cause dermatologic toxicity, which may be severe. Clinical manifestations included, but were not limited to, rash, pruritus, paronychia, dry skin, and skin fissures. In clinical trials of patients with pancreatic adenocarcinoma, dermatologic toxicity occurred in 86% of patients treated with RASONQUE, of which 10% were Grade 3.

Monitor patients who develop dermatologic or soft tissue toxicities while receiving RASONQUE. Initiate prophylactic measures (e.g., topical corticosteroids, emollient creams, sunscreen, oral antibiotics) prior to the first dose of RASONQUE to reduce the risk of moderate to severe dermatologic reactions. Advise patients to limit sun exposure while taking RASONQUE. Initiate supportive measures (e.g., oral corticosteroids) as clinically indicated, and consider dermatologic consultation. Withhold, reduce the dose, or permanently discontinue RASONQUE based on severity.

Stomatitis and Oral Disorders

RASONQUE can cause stomatitis, including mouth ulcers and oral mucositis. In clinical trials of patients with pancreatic adenocarcinoma, stomatitis occurred in 57% of patients, of which 9% were Grade 3.

Monitor patients for signs and symptoms of stomatitis while receiving RASONQUE. Initiate a steroid-containing mouthwash for treatment of stomatitis and administer other topical treatments (e.g., chlorhexidine mouthwash, 2% lidocaine viscous) as clinically indicated. Withhold, reduce the dose, or permanently discontinue RASONQUE based on severity.

Diarrhea

RASONQUE can cause diarrhea. In clinical trials of patients with pancreatic adenocarcinoma, diarrhea occurred in 63% of patients, of which 6% were Grade 3.

If diarrhea occurs, administer antidiarrheal treatment as clinically indicated. Withhold, reduce the dose, or permanently discontinue RASONQUE based on severity.

Gastrointestinal Perforation

RASONQUE can cause gastrointestinal perforation. In clinical trials of patients with pancreatic adenocarcinoma, gastrointestinal perforation occurred in 0.9% of patients treated with RASONQUE, of which 0.5% were Grade 3, one event was Grade 4, and one event was fatal.

Monitor patients for gastrointestinal perforation. Withhold RASONQUE if gastrointestinal perforation is suspected. Reduce the dose or permanently discontinue RASONQUE if no other potential causes of gastrointestinal perforation are identified.

Interstitial Lung Disease (ILD)/Pneumonitis

RASONQUE can cause interstitial lung disease or pneumonitis. In clinical trials of patients with pancreatic adenocarcinoma, ILD/pneumonitis occurred in 2.4% of patients treated with RASONQUE, of which 0.9% were Grade 3, and one event was fatal.

Monitor patients for new or worsening pulmonary symptoms. Withhold RASONQUE if ILD/pneumonitis is suspected. Reduce the dose or permanently discontinue RASONQUE if no other potential causes of ILD/pneumonitis are identified.

Embryo-Fetal Toxicity

Based on findings in animals, RASONQUE can cause fetal harm when administered to a pregnant woman. Advise females of reproductive potential to use effective contraception during treatment with RASONQUE and for 1 week after the last dose. Advise males with female partners of reproductive potential to use effective contraception during treatment with RASONQUE and for 1 week after the last dose.

ADVERSE REACTIONS

Serious adverse reactions occurred in 30% of patients treated with RASONQUE. Serious adverse reactions occurring in ≥ 2% of patients treated with RASONQUE were diarrhea (3.7%), pyrexia (3.3%), sepsis (2.9%), fatigue (2.1%), and hemorrhage (2.1%).

Adverse reactions leading to permanent discontinuation of RASONQUE occurred in 2.9% of patients, including two patients who discontinued due to rash (0.8%).

The most common (≥ 20%) adverse reactions in patients treated with RASONQUE were rash, diarrhea, stomatitis, nausea, fatigue, vomiting, abdominal pain, edema, decreased appetite, and hemorrhage.

DRUG INTERACTIONS

Strong CYP3A Inhibitors with P-gp Inhibition: Avoid concomitant use.Strong CYP3A Inhibitors without P-gp Inhibition: Reduce RASONQUE dosage.Moderate CYP3A Inhibitors with or without P-gp Inhibition: Reduce RASONQUE dosage.P-gp Inhibitors: Reduce RASONQUE dosage.Cyclosporine A: Avoid concomitant use.Strong CYP3A Inducers: Avoid concomitant use. Increase RASONQUE dosage if concomitant use cannot be avoided.Moderate CYP3A Inducers: Increase RASONQUE dosage.P-gp Substrates: Take at least 4 hours apart from RASONQUE.
  PROPHYLACTIC MEASURES

When initiating RASONQUE and throughout treatment, prophylactic and concomitant medications are recommended to reduce the risk of dermatologic reactions:

administer a topical corticosteroid (applied to the face and chest) and emollient creamsadvise patients to limit sun exposure and use broad-spectrum sunscreen (SPF 30 or higher)consider prophylactic oral antibiotics (e.g., doxycycline or minocycline) About Revolution Medicines, Inc.

Revolution Medicines is a global, commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide. For more information, visit www.revmed.com and follow Revolution Medicines on LinkedIn, X (Twitter) and Instagram.

Forward-Looking Statements 
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this press release that are not historical facts may be considered "forward-looking statements," including without limitation statements regarding the broad potential of RAS(ON) inhibition; the review of the CHMP Opinion by the EC; the availability of RASONQUE in Europe and other jurisdictions; treatment practices; the company’s regulatory interactions; and reactions to RASONQUE; and progression of clinical studies and findings from these studies, including the tolerability, safety, and potential efficacy of the company's candidates being studied.

Forward-looking statements are typically, but not always, identified by the use of words such as "aims," "anticipate," "believe," "estimate," "expect," "plan," "potential," "project," "up to," "will" and other similar terminology indicating future results. Such forward-looking statements are subject to substantial risks and uncertainties that could cause the company's development programs, future results, performance, or achievements to differ materially from those anticipated in the forward-looking statements. Such risks and uncertainties include without limitation risks and uncertainties inherent in the drug development process, including the company's programs' development stages, the process of designing and conducting preclinical and clinical trials, the regulatory approval processes, the timing of regulatory filings, the challenges associated with manufacturing drug products, the company's ability to successfully establish, protect and defend its intellectual property, other matters that could affect the sufficiency of the company's capital resources to fund operations, reliance on third parties for manufacturing and development efforts, changes in the competitive landscape, and the effects on the company's business of global events, such as international conflicts or global pandemics. For a further description of the risks and uncertainties that could cause actual results to differ from those anticipated in these forward-looking statements, as well as risks relating to the business of Revolution Medicines in general, see Revolution Medicines' Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the "SEC") on August 5, 2026, and its future periodic reports to be filed with the SEC. Except as required by law, Revolution Medicines undertakes no obligation to update any forward-looking statements to reflect new information, events, or circumstances, or to reflect the occurrence of unanticipated events.

Revolution Medicines Media & Investor Contacts 

Media
[email protected]  

Investors
[email protected] 

References

1 Hawksworth G, Hales J, Martinez F, et al. Pancreatic cancer trends in Europe: epidemiology and risk factors. Med Stud. 2019;35(2):164-171. doi:10.5114/ms.2019.86336
2 International Agency for Research on Cancer. Pancreas. Global Cancer Observatory. https://gco.iarc.who.int/today/en/fact-sheets-cancers/13/pancreas. Accessed September 2026. 
3 Rahib L, Coffin T, Kenner B. Factors driving pancreatic cancer survival rates. Pancreas. 2025;54(6):e530-e536. doi:10.1097/MPA.0000000000002489
4 RASONQUE (daraxonrasib) Prescribing Information. Redwood City, CA: Revolution Medicines, Inc.; August 2026.

Krilogy Financial LLC increased its holdings in shares of Broadridge Financial Solutions, Inc. (NYSE:BR – Free Report) by 807.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 15,456 shares of the business services provider’s stock after acquiring an additional 13,752 shares during the quarter. Krilogy Financial LLC’s holdings in Broadridge Financial Solutions were worth $2,490,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Financial Planning Hawaii Inc. lifted its holdings in Broadridge Financial Solutions by 28.9% during the 3rd quarter. Financial Planning Hawaii Inc. now owns 3,126 shares of the business services provider’s stock valued at $504,000 after purchasing an additional 700 shares during the last quarter. Sax Wealth Advisors LLC boosted its position in Broadridge Financial Solutions by 547.4% during the third quarter. Sax Wealth Advisors LLC now owns 9,355 shares of the business services provider’s stock worth $1,507,000 after purchasing an additional 7,910 shares during the period. Fragasso Financial Advisors Inc boosted its position in Broadridge Financial Solutions by 14.2% during the third quarter. Fragasso Financial Advisors Inc now owns 1,836 shares of the business services provider’s stock worth $304,000 after purchasing an additional 228 shares during the period. NorthCrest Asset Manangement LLC bought a new position in Broadridge Financial Solutions during the third quarter worth $2,474,000. Finally, Tilia Fiduciary Partners Inc. increased its holdings in shares of Broadridge Financial Solutions by 8.7% in the third quarter. Tilia Fiduciary Partners Inc. now owns 15,089 shares of the business services provider’s stock valued at $2,431,000 after purchasing an additional 1,205 shares during the last quarter. 90.03% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth Several brokerages have recently weighed in on BR. Morgan Stanley increased their price objective on shares of Broadridge Financial Solutions from $169.00 to $176.00 and gave the company an “equal weight” rating in a research report on Thursday, August 6th. Weiss Ratings upgraded shares of Broadridge Financial Solutions from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, October 8th. UBS Group reaffirmed a “neutral” rating and set a $180.00 target price on shares of Broadridge Financial Solutions in a report on Monday, August 17th. Finally, Royal Bank Of Canada lifted their target price on shares of Broadridge Financial Solutions from $225.00 to $226.00 and gave the stock an “outperform” rating in a report on Monday, August 31st. Four analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, Broadridge Financial Solutions currently has a consensus rating of “Moderate Buy” and a consensus target price of $216.00.

Check Out Our Latest Report on BR Insider Buying and Selling In other Broadridge Financial Solutions news, VP Thomas Carey sold 2,501 shares of the stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $159.76, for a total transaction of $399,559.76. Following the transaction, the vice president owned 8,800 shares in the company, valued at $1,405,888. This trade represents a 22.13% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 1.00% of the stock is currently owned by corporate insiders.

Broadridge Financial Solutions Price Performance Broadridge Financial Solutions stock opened at $168.15 on Thursday. Broadridge Financial Solutions, Inc. has a 12 month low of $133.83 and a 12 month high of $236.02. The stock’s 50 day moving average is $169.80 and its 200-day moving average is $157.66. The company has a current ratio of 1.24, a quick ratio of 1.24 and a debt-to-equity ratio of 1.15. The company has a market capitalization of $18.98 billion, a price-to-earnings ratio of 17.48 and a beta of 0.92.

Broadridge Financial Solutions (NYSE:BR – Get Free Report) last announced its earnings results on Tuesday, August 4th. The business services provider reported $3.82 earnings per share for the quarter, topping analysts’ consensus estimates of $3.76 by $0.06. The company had revenue of $2.22 billion for the quarter, compared to analyst estimates of $2.17 billion. Broadridge Financial Solutions had a return on equity of 40.25% and a net margin of 15.04%. The firm’s quarterly revenue was up 7.5% compared to the same quarter last year. During the same quarter last year, the company earned $3.55 earnings per share. Broadridge Financial Solutions has set its FY 2027 guidance at 10.370-10.750 EPS. Equities research analysts expect that Broadridge Financial Solutions, Inc. will post 10.54 EPS for the current year.

Broadridge Financial Solutions Increases Dividend The company also recently disclosed a quarterly dividend, which was paid on Monday, October 5th. Shareholders of record on Thursday, September 3rd were issued a $1.09 dividend. The ex-dividend date of this dividend was Thursday, September 3rd. This represents a $4.36 dividend on an annualized basis and a yield of 2.6%. This is a positive change from Broadridge Financial Solutions’s previous quarterly dividend of $0.9750. Broadridge Financial Solutions’s payout ratio is currently 45.32%.

(Free Report)

Broadridge Financial Solutions, Inc is a financial technology and services company that provides communications, technology and data solutions to financial institutions, public companies and other organizations. Its platforms support critical business processes across investor communications, capital markets, wealth management and corporate governance.

The company’s services include proxy and regulatory communications, shareholder and customer communications, securities processing, trading and operations technology, portfolio and wealth management tools, and governance solutions.

Featured Stories Five stocks we like better than Broadridge Financial Solutions Tesla Wants to Make Its Own Chips—What Could Go Wrong? IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver? PBF Energy’s Stunning Rally Faces a Critical Test Citi Stock Falls Despite Earnings Beat: What Investors Need to Know

Receive News & Ratings for Broadridge Financial Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Broadridge Financial Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

F&G's Fourth Annual Retirement Reconsidered Survey Finds That Americans Are Rethinking When They Retire and What Retirement Looks Like
51% of Pre-retirees Plan to Semi-retire, While 75% Have Considered or Are Delaying Retirement

, /PRNewswire/ -- Retirement is becoming less of a single moment when Americans stop working and more of a gradual transition, according to the fourth annual Retirement Reconsidered survey from F&G Annuities & Life, Inc. (NYSE: FG) (F&G), a leading provider of insurance solutions serving retail annuity and life customers and institutional clients. Nearly one third (31%) of surveyed Americans over the age of 50 consider themselves semi-retired or plan to be. More than half of respondents who are not yet retired (51%) say they plan to semi-retire. At the same time, three-quarters (75%) of pre-retirees have considered or are delaying their retirement date, up from 70% in 2025.

Americans Aren't Just Delaying Retirement, They're Redesigning It

The survey underscores how many Americans over age 50 are rethinking retirement and how the traditional definition is evolving to become more flexible and personalized with Generation X (Gen X) and pre-retirees driving this trend. Other key findings include:

More than half (53%) of Americans ages 50+ agree the journey to retirement is becoming more flexible
60% of pre-retirees see retirement as a "gradual transition over time"
Only 21% of pre-retirees associate retirement with stopping work completely
Nearly two thirds (65%) of pre-retirees view retirement as an opportunity to reinvent themselves

"Americans, no matter their savings or income bracket, aren't simply reconsidering when they retire; they're reconsidering what retirement itself looks like," said Conor Murphy, CEO and President of F&G. "For some, that means choosing to work less, transitioning gradually into retirement or even reinventing themselves in a new chapter, while for others, original plans are giving way to financial realities. As retirement becomes more flexible and individualized, it's important to provide retirees and pre-retirees with accessible planning solutions to evolve with changing needs and allow for greater certainty and confidence along the way."

Outside Forces Are Reshaping Retirement Plans

Even as retirement itself becomes more flexible, financial and economic pressures continue to reshape Americans' plans. More than half (51%) of pre-retirees surveyed say they expect to retire later than originally planned, up from 45% in 2025. For those considering or delaying retirement, 52% worry they won't have enough money, up from 48% last year.

Other financial uncertainties are also weighing on retirement decisions. Social Security availability (46%) tops the list of factors influencing retirement planning among Americans age 50 and above, followed closely by healthcare/long-term care expenses (43%) and Medicare availability (31%).

The evolution of retirement also comes as Americans age 50 and over report that economic and other external factors are having a greater impact on their decision-making than they did a year ago. More than half (57%) say the events of 2026 have impacted their retirement planning, up from 49% in 2025. Among pre-retirees, that rose to 70%, up from 61% last year.

The impact is even more pronounced among Gen X, with more than two-thirds (68%) saying the events of 2026 have affected their retirement decision-making, up 11 percentage points from last year. By comparison, about half of Baby Boomers (51%) say the same today.

Seeking Predictability in an Uncertain Retirement Landscape

Even as Americans surveyed embrace greater flexibility in how retirement looks, the findings show a strong preference for financial certainty and predictability, alongside concerns about retirement readiness, particularly among Gen X.

Key findings include:

Three-quarters (75%) would rather have greater financial certainty and predictable income, even if it limits investment growth potential
Two-thirds (67%) say they feel the need to invest or increase investment in products that deliver guaranteed income in the future, rising to 73% among Gen X
Only 11% of Gen X give themselves an A for financial readiness as they prepare for retirement, compared with 20% of Americans ages 50+ overall

"The roadmap to retirement is no longer a straight line, which makes personalized financial planning increasingly important," said Ron Barrett, Chief Distribution Officer at F&G. "A financial professional can help individuals think through how their assets will support the different stages of retirement and secure a financial legacy through a customized plan that provides predictability along the way. Guaranteed income products, such as annuities, and protection products, such as indexed universal life insurance, can be important parts of that conversation by helping provide reliable income and greater financial confidence throughout retirement, no matter what path that journey takes."

For more information on F&G's latest survey, please visit fglife.com/research. 

Survey Methodology

This research was conducted by Censuswide, among a sample of 2001 US Adults Aged 50+, 'decision-makers' for household finances (or shared decision making), with $100k+ investable assets. The data was collected between 8/4/2026 – 8/31/2026.

About F&G

F&G Annuities & Life, Inc. is committed to helping Americans turn their aspirations into reality. F&G is a leading provider of insurance solutions serving retail annuity and life customers and institutional clients and is headquartered in Des Moines, Iowa. For more information, please visit fglife.com.    

Media Contact

Gabrielle Simon
pro-F&[email protected]
413.695.3818

Investor Contact:

Lisa Foxworthy-Parker
SVP of Investor & External Relations
515.330.3307
[email protected]

SOURCE F&G Annuities & Life, Inc.

-

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced it will deliver Redwire’s Stalker Uncrewed Aircraft Systems (UAS) in support of the National Guard Bureau’s evolving mission requirements and UAS modernization priorities. The value of the purchase orders was approximately $13.8 million.

“The Stalker UAS offers advanced multi-mission capabilities and operational durability in extreme environments. We are incredibly proud to partner with the National Guard Bureau," said Joshua Stinson, Co-President and CGO at Redwire Defense Tech.

Share The long range, Group 2 Stalker UAS will provide National Guard instructors with a highly reliable, modular platform to train incoming soldiers on complex flight operations, field maintenance, and multi-mission payload deployment. Stalker serves as an ideal bridge for this advanced training environment due to its ease of use and sophisticated yet highly learnable architecture.

"As the threat environment evolves so do mission requirements, and the National Guard requires versatile operators who are trained on combat proven aircraft that are ready to field," said Joshua Stinson, Co-President and Chief Growth Officer at Redwire Defense Tech. “The Stalker UAS offers advanced multi-mission capabilities and operational durability in extreme environments. We are incredibly proud to partner with the National Guard Bureau to equip guardsmen with the hands-on experience they need to ensure domestic readiness and overseas mission success."

National guardsmen will utilize Stalker to master critical competencies required by the U.S. Army’s newest Military Occupational Specialty (MOS): the 15X Tactical UAS Specialist. The 15X MOS represents a major paradigm shift in military aviation, combining the traditional roles of UAS operator and maintainer into a single, highly adaptable operator. Guardsmen trained under this curriculum are expected to embed within maneuver formations to operate, maintain, and rapidly troubleshoot Group 1 through Group 3 systems at the tactical edge.

By deploying the combat proven Stalker across key regional training sites, including Camp Shelby, Mississippi and Fort Indiantown Gap, Pennsylvania, the National Guard Bureau is pursuing standardized, high-tier instruction that replicates the multi-domain challenges guardsmen will face when integrated into brigade and lower-level maneuver units.

Redwire specializes in delivering innovative and combat proven uncrewed aircraft, advanced optics, and resilient energy solutions that are used by allied government and civilian operations worldwide. With nearly three decades of technology heritage and manufacturing expertise, Redwire’s experienced team delivers proven solutions based on real-world mission needs.

About Redwire
Redwire Corporation (NYSE: RDW) is an integrated space and defense tech company focused on advanced technologies. We are building the future of aerospace infrastructure, autonomous systems, and multi-domain operations leveraging digital engineering and AI automation. Redwire’s approximately 1,400 employees located throughout North America and Europe are committed to delivering innovative space and airborne platforms transforming the future of multi-domain operations. For more information, please visit RDW.com.

More News From Redwire Corporation

Back to Newsroom

Sax Wealth Advisors LLC acquired a new position in shares of Sandisk Corporation (NASDAQ:SNDK – Free Report) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 684 shares of the data storage provider’s stock, valued at approximately $1,190,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Handelsbanken Fonder AB boosted its stake in shares of Sandisk by 35.1% in the second quarter. Handelsbanken Fonder AB now owns 57,564 shares of the data storage provider’s stock worth $130,885,000 after acquiring an additional 14,964 shares during the last quarter. Focus Partners Advisor Solutions LLC purchased a new stake in shares of Sandisk during the second quarter worth approximately $4,775,000. Florida Financial Advisors LLC purchased a new stake in shares of Sandisk during the first quarter worth approximately $2,747,000. UNICOM Systems Inc. increased its position in shares of Sandisk by 14.9% during the second quarter. UNICOM Systems Inc. now owns 58,500 shares of the data storage provider’s stock worth $133,013,000 after purchasing an additional 7,600 shares in the last quarter. Finally, Affinity Capital Advisors LLC acquired a new position in Sandisk in the 2nd quarter valued at $2,506,000.

Insider Transactions at Sandisk In related news, CEO David Goeckeler sold 33,841 shares of Sandisk stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $1,574.21, for a total value of $53,272,840.61. Following the completion of the transaction, the chief executive officer owned 382,865 shares in the company, valued at approximately $602,709,911.65. The trade was a 8.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Luis Visoso sold 1,000 shares of the company’s stock in a transaction on Tuesday, September 15th. The stock was sold at an average price of $1,568.83, for a total value of $1,568,830.00. Following the sale, the chief financial officer directly owned 130,976 shares in the company, valued at $205,479,078.08. This represents a 0.76% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 77,899 shares of company stock valued at $121,159,122. Corporate insiders own 0.29% of the company’s stock.

Analyst Upgrades and Downgrades Several equities analysts have recently weighed in on SNDK shares. Rosenblatt Securities started coverage on shares of Sandisk in a research note on Tuesday, September 22nd. They issued a “buy” rating and a $2,400.00 price target on the stock. Wells Fargo & Company boosted their price target on shares of Sandisk from $1,400.00 to $1,550.00 and gave the company an “equal weight” rating in a research report on Thursday, August 13th. Jefferies Financial Group reissued a “buy” rating and issued a $1,400.00 price objective (up from $1,000.00) on shares of Sandisk in a report on Thursday, August 6th. JPMorgan Chase & Co. started coverage on shares of Sandisk in a research report on Friday, August 14th. They set an “overweight” rating and a $2,250.00 price objective for the company. Finally, Sanford C. Bernstein restated an “outperform” rating and set a $3,000.00 price objective (up from $1,700.00) on shares of Sandisk in a research report on Thursday, August 6th. Two analysts have rated the stock with a Strong Buy rating, twenty-two have given a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, Sandisk presently has a consensus rating of “Moderate Buy” and a consensus price target of $2,120.65. Check Out Our Latest Stock Analysis on SNDK

Sandisk Trading Down 5.3% NASDAQ SNDK opened at $1,403.34 on Thursday. The stock has a fifty day simple moving average of $1,599.14 and a 200-day simple moving average of $1,492.85. The stock has a market cap of $202.82 billion, a PE ratio of 19.25, a P/E/G ratio of 0.15 and a beta of 5.23. Sandisk Corporation has a twelve month low of $130.50 and a twelve month high of $2,354.39.

Sandisk (NASDAQ:SNDK – Get Free Report) last posted its earnings results on Wednesday, August 5th. The data storage provider reported $39.25 EPS for the quarter, beating analysts’ consensus estimates of $33.28 by $5.97. The company had revenue of $8.96 billion for the quarter. Sandisk had a net margin of 56.47% and a return on equity of 87.84%. The company’s quarterly revenue was up 371.6% compared to the same quarter last year. During the same period in the previous year, the company earned $0.29 EPS. Sandisk has set its Q1 2027 guidance at 44.000-46.000 EPS. Research analysts predict that Sandisk Corporation will post 208.94 EPS for the current year.

Sandisk declared that its board has approved a stock buyback program on Wednesday, August 5th that authorizes the company to repurchase $14.00 billion in shares. This buyback authorization authorizes the data storage provider to repurchase up to 6.6% of its stock through open market purchases. Share buyback programs are usually an indication that the company’s board of directors believes its shares are undervalued.

Key Headlines Impacting Sandisk Here are the key news stories impacting Sandisk this week:

Positive Sentiment: SanDisk entered a partnership with Meta Platforms to provide data-storage options for Meta’s VR glasses, supporting the company’s exposure to artificial intelligence, augmented reality and other long-term data-demand trends. SanDisk Stock Drops Despite Data Storage Partnership With Meta Positive Sentiment: Analyst Nicholas Mugalli reiterated a highly bullish long-term view, projecting a $3,000 price target and arguing that future earnings could make the valuation appear inexpensive. Other analysts also describe SNDK as an attractive buy-the-dip opportunity because of sustained AI-related memory demand. SanDisk Has More Upside Positive Sentiment: S&P Global upgraded SanDisk’s credit rating to BBB from BB+, citing stronger cash flows and rising AI-driven memory demand. A bullish investment case also points to robust NAND pricing, long-term contracts and financial guarantees. SanDisk Credit Rating Upgrade Neutral Sentiment: Strong third-quarter results from semiconductor-equipment maker ASML and continued expectations for AI infrastructure growth provide support for memory demand, but have not been enough to overcome current sector selling. Why Memory Stocks Are Falling Despite ASML Results Negative Sentiment: Chinese memory maker CXMT’s advances and plans to target high-end server memory are raising fears that new competition could pressure SanDisk’s pricing, market share and expected memory-cycle profits. Why Memory Stocks Are Falling Negative Sentiment: Hotter-than-expected U.S. inflation has increased macroeconomic and interest-rate uncertainty, while concerns about AI funding and stretched semiconductor valuations are adding to the sector-wide selloff. Market Open News About Sandisk (Free Report)

SanDisk Corporation offers flash storage solutions. The Company designs, develops and manufactures data storage solutions in a range of form factors using flash memory, controller, firmware and software technologies. The Company operates through flash memory storage products segment. Its solutions include a range of solid state drives (SSD), embedded products, removable cards, universal serial bus (USB), drives, wireless media drives, digital media players, and wafers and components. It offers SSDs for client computing applications, which encompass desktop computers, notebook computers, tablets and other computing devices.

Featured Stories Five stocks we like better than Sandisk Tesla Wants to Make Its Own Chips—What Could Go Wrong? IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver? PBF Energy’s Stunning Rally Faces a Critical Test Citi Stock Falls Despite Earnings Beat: What Investors Need to Know Want to see what other hedge funds are holding SNDK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sandisk Corporation (NASDAQ:SNDK – Free Report).

Receive News & Ratings for Sandisk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandisk and related companies with MarketBeat.com's FREE daily email newsletter.

Optimizes service parts across complex global supply network
Transforms planning productivity through exception-based management
AI-powered intelligence built on deep service supply chain expertise and proven optimization science
, /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that the United States Air Force (USAF) has extended its use of PTC's Servigistics® service supply chain optimization solution as part of its Enterprise Supply Chain Analysis, Planning, and Execution (ESCAPE) program. The renewal extends a nearly decade-long relationship focused on modernizing the Air Force service supply chain and improving aircraft and system readiness.

Copyright Image: (U.S. Air Force photo/Ken Wright).

The U.S. Air Force first selected Servigistics in 2017 to transform service parts planning across its global supply chain. Its use of the solution has since expanded to support more sophisticated planning and optimization requirements, consolidate legacy systems, and modernize its supply chain planning environment. Today, Servigistics helps the Air Force align inventory and supply decisions with aircraft and system availability objectives by combining advanced forecasting, multi-echelon optimization, supply planning, machine learning, and AI to ensure critical parts are available where and when they are needed.

"Readiness depends on our ability to anticipate requirements and make effective supply chain decisions in an increasingly complex operational environment," said Abigail Strobell, Deputy Chief, U.S. Air Force. "Our continued use of Servigistics enables us to build on the progress we have made in modernizing service parts planning and strengthen the supply chain capabilities that support aircraft availability."

The renewal marks the next phase of this journey, creating opportunities to leverage continued innovation in AI and exception-based management so planners can identify emerging issues, evaluate alternatives, automate routine workflows, and focus expert attention on decisions that require intervention.

With Servigistics and the rest of its portfolio, PTC is delivering on its vision for the Intelligent Product Lifecycle: enabling manufacturers to build a modern product data foundation, extend that data across the enterprise, and unlock AI‑powered transformation. Broader use of product data enables companies to bring higher‑quality products to market faster, manage complexity at scale, and support new digital business models.

About PTC   
PTC (NASDAQ: PTC) is a global software company that enables manufacturers and product companies to digitally transform how they design, manufacture, and service the physical products that the world relies on. Headquartered in Boston, Massachusetts, PTC employs over 7,000 people and supports more than 30,000 customers globally. For more information, please visit www.ptc.com.  

Media Contact
Libby Fink: [email protected]

Investor Contact
Michael Maguire: [email protected]

PTC, Servigistics and the PTC logo are trademarks or registered trademarks of PTC Inc. and its subsidiaries in the United States and other countries.  

SOURCE PTC Inc.

Apple Inc. (NASDAQ:AAPL) is trending Thursday after a Bloomberg report that the company plans to release Apple Intelligence in mainland China in December as part of the iOS 27.3 update.

Apple shares are testing new highs. Why is AAPL stock breaking out? Apple Plans a Limited Apple Intelligence Launch in China in DecemberAccording to Investing.com, Bloomberg reported Wednesday, citing people familiar with the matter, that the launch will include AI features that first became available in the U.S. two years ago on the iPhone, iPad and Mac. The new Siri AI assistant and other features Apple announced this year won’t be part of the December release. Apple received preliminary approval in July to introduce Apple Intelligence in China and recently held more discussions with the country’s Ministry of Industry and Information Technology about clearance for a consumer debut.

The rollout follows years of preparation and several delays. Apple initially expected a release in May 2025, then pushed it to the end of 2025 and again to spring 2026 while waiting for Chinese government approval. Apple hasn’t confirmed a launch date.

Alibaba and Baidu Reportedly Power the China Version, With a Government FilterChina restricts foreign AI technology, so Apple has partnered with local companies. Alibaba confirmed in July that its Qwen model will power Apple Intelligence features for Chinese users, and Baidu is reportedly handling search and some Siri features. Bloomberg reported that Apple and Alibaba built safeguards that include a process for the government to approve ongoing model updates.

Updated network access permits from the Ministry of Industry and Information Technology, completed September 29, list Apple Intelligence alongside Alibaba’s Qwen and Tongyi Wanxiang models for the iPhone Duo, iPhone 18 Pro and earlier iPhones, according to the South China Morning Post.

Why China Matters to AppleGreater China revenue rose 22.4% from a year earlier to $18.8 billion in Apple’s fiscal third quarter, which ended in June, according to Tech Times. Apple Intelligence has been missing from the market since the features debuted globally, and AppleInsider noted it remains to be seen whether the launch will help iPhone sales in China when local competitors ship more capable AI models on their phones.

Read Next

Apple Shares Trade FlatAAPL Price Action: At the time of publication, Apple shares are trading 0.76% higher at $345.58, according to data from Benzinga Pro.

Image via Shutterstock

This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Uber sits 30% below its 52-week high while robotaxi fears and weak guidance batter the stock, but one Wall Street analyst just planted a flag that stands far above where even the bulls are willing to go.

Uber Technologies (NYSE:UBER | UBER Price Prediction) is trading at $69.31. The average price target among analysts is $100.86, which implies 45.5% upside.

Uber runs a global platform for rides, delivery and freight. It has 208 million monthly active platform consumers and recorded $58.02 billion in quarterly gross bookings. The question hanging over the stock all year is whether robotaxis make Uber the essential aggregator or cut it out of the trip.

One analyst has an unusually clear answer. Evercore ISI’s Mark Mahaney holds a Street-high $150.00 target, which implies 116.4% upside. He expects the stock to more than double. Price targets usually look about 12 months out, so that is a bold call.

Weak Guidance and Robotaxi Fears Left Uber 30% Below Its High
The biggest hit came from guidance. Uber forecast third-quarter adjusted EPS of 84 cents to 88 cents, below the 89 cents analysts expected, and shares fell 4.8%. The second quarter also missed. EPS came in at $0.81 versus $0.833 expected, and revenue was $14.19B versus $14.26B.

On the same call, Uber laid out plans to spend more than $10 billion on robotaxis. This came amid reports that Waymo was considering ending the two companies’ partnership. Investors were already examining capital allocation after the $14.80-billion Delivery Hero deal.

The stock is now 30.9% below its 52-week high of $100.35. That is a severe decline for a megacap. Self-driving headlines keep adding pressure. Uber fell 2.82% in the latest session as investors digested more self-driving news tied to Tesla (NASDAQ:TSLA). The S&P 500 slipped only 1.07% that day.

Evercore’s $150 Case Rests on Uber Becoming the Robotaxi Middleman
Mahaney’s first point is that Uber becomes the network orchestrator for autonomous fleets. Management is pushing the same story. Uber is live in seven AV cities and targets 15 cities by year end. It says partner vehicles reach “mid to high 20s, low 30s” trips per vehicle per day. The CEO, Dara Khosrowshahi, put the goal simply: “Our ambition is straightforward, to become the world’s leading commercialization platform for autonomous vehicles.”

The second point is delivery and cash generation. Delivery revenue grew 28%, and segment operating income rose 38% to $1.05B. Trailing free cash flow exceeded $10 billion for the first time. Management also said bigger buybacks will return in “months, not quarters.”

Most of the Street agrees. Of 51 analysts, 9 rate it Strong Buy, 33 Buy, 8 Hold and 1 Sell. Over the last 30 days, analysts revised 2027 EPS estimates up 7 times and down 2 times. Even so, the consensus dipped to $4.5379 from $4.6559 a month earlier. The CEO is adding shares: he bought 141,000 shares on the open market at $70.9642.

A skeptic would point out that the $150 target only works if the market starts treating AV spending as an asset. Management itself warned of a future “P&L impact.”

Lyft and DoorDash Fell Too, but Uber Shows the Widest Gap
The selloff spread across the group. Lyft (NASDAQ:LYFT) is down 14.92% year to date at $16.48. Its average target of $19.47 implies just 18.1% upside, and 31 of 45 analysts rate it Hold.

DoorDash (NASDAQ:DASH) is down 18.75% year to date and 9.6% over the past month. Trading at $184.01, it is well below its $257.37 target, which implies 39.9% upside. It carries 9 Strong Buy, 27 Buy and 10 Hold ratings.

Uber has the largest consensus upside in the group. DoorDash comes close, but it trades at a forward P/E of 38, compared with Uber’s 16.

Uber Has Lagged the S&P 500 by a Wide Margin This Year
At $69.31, Uber has 45.5% upside to the $100.86 consensus target set by 51 analysts. Shares are down 15.18% year to date and 26.46% over the past year. The S&P 500 has gained 12.86% year to date.

The valuation now looks low. Uber trades at about 16 times forward earnings with a free cash flow yield near 6.9%.

Robotaxi Execution Will Decide Whether Uber’s Discount Closes
The bull case improves if Uber reaches 15 AV cities on schedule, keeps Waymo alongside newer partners and resumes big buybacks. If that happens, a re-rating toward $100 looks reasonable. Risks grow if AV spending cuts into margins, Waymo walks away, or competition like Brazil’s “enormous amount of competition” starts dragging on bookings. In that case, today’s low multiple would turn out to be a value trap.

The balance of evidence leans bullish. A CEO buying stock on the open market and a mid-teens multiple on a business with $10 billion of free cash flow make a strong case. Mahaney’s $150 is the best-case outcome. The consensus target of roughly $100 is the more realistic goal.

Contact [email protected] for any questions or corrections.

Amazon’s personal AI wearable maker, Bee, is announcing its first new products since being acquired by the retail giant last year. The tech company on Thursday introduced the Bee Frontier, the next generation of its device that can be worn on the wrist or pinned to clothes, along with Bee Eclipse, a credit-card-sized device that magnetically attaches to the back of your smartphone.

The latter puts Bee into more direct competition with AI devices like the Plaud Note or Pocket, but at a lower price point — the Bee Frontier is $74.99, compared with $159 for the Plaud Note (or $189 for the Note Pro), or $129 for the Pocket AI device.

The Bee Frontier will come in Onyx, Lavender, and Sage, while the $99.99 Bee Eclipse will be offered in Silver, Midnight, Honey, and Blush.

Like the original Bee, the idea with the new devices is to leverage AI to take notes from your everyday conversations, allowing you to remember the important things that were said, and then turn those into actionable to-dos, summaries, and insights.

For instance, if you discussed making plans with friends, the Bee would remember the date and time you agreed on, then create a calendar invite. You could also use the Bee to take lecture notes in class, or to jot down the care plan you discussed with a doctor, among other things.

All Bee devices can create conversation summaries and recaps for free, and offer 14 days of memory. With an $11.99 per month Bee Pro subscription, users receive unlimited conversation summaries and integrations with Amazon.com, Alexa+, and third-party applications. Pro users also get suggested to-dos, daily memories, a personal chat assistant, and conversation templates.

To make all this possible, Bee devices use a private computing security architecture, which doesn’t store the raw audio from your conversations. Instead, audio is processed in real time and then deleted. Transcripts of the conversation are encrypted using keys that your device creates and controls, which means no one else, including Amazon employees, can access those files unless you manually and intentionally share them.

In addition, you can opt to connect the Bee to Alexa, allowing your Echo device to use its ability to identify your voice, a feature called Voice ID, to recognize when you’re speaking. It can then record your conversations to provide Bee’s insights. (This aspect of Bee is optional, and Amazon notes you can delete transcripts and summaries at any time.)

With its new connections to Amazon.com and Alexa, Bee users can make purchases from Amazon or ask Alexa for their Bee insights, summaries, or to-dos hands-free.

Bee also works with your existing productivity software, like Gmail, Google Calendar, and Microsoft Outlook, so it can draft emails, set up meetings, surface action items, and more.

Plus, you can upload photos to Bee or connect it with Apple’s HealthKit to add a picture of your overall wellness to be integrated into your provided insights.

The Bee Frontier and Bee Eclipse both have just one button that turns the device off and on, and include an indicator light when it’s summarizing a conversation. The Frontier also offers IP67 water resistance, up to seven days of battery life, USB-C charging, and dual microphones with advanced noise filtering.

All Bee devices come with a companion mobile app, which has also been newly redesigned, plus a new desktop app.

The Bee Frontier is available now on Amazon, and the Eclipse will be available soon thereafter.

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.

Sarah has worked as a reporter for TechCrunch since August 2011. She joined the company after having previously spent over three years at ReadWriteWeb. Prior to her work as a reporter, Sarah worked in I.T. across a number of industries, including banking, retail and software.

You can contact or verify outreach from Sarah by emailing [email protected] or via encrypted message at sarahperez.01 on Signal.

Landscape Capital Management L.L.C. acquired a new position in Microsoft Corporation (NASDAQ:MSFT – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 2,822 shares of the software giant’s stock, valued at approximately $1,053,000.

A number of other large investors have also recently made changes to their positions in MSFT. Auto Owners Insurance Co increased its stake in Microsoft by 56,160.8% during the fourth quarter. Auto Owners Insurance Co now owns 60,116,384 shares of the software giant’s stock worth $29,073,486,000 after acquiring an additional 60,009,531 shares during the last quarter. Corient Private Wealth LLC lifted its stake in shares of Microsoft by 234.5% in the 4th quarter. Corient Private Wealth LLC now owns 17,822,280 shares of the software giant’s stock valued at $8,619,211,000 after purchasing an additional 12,493,786 shares during the last quarter. Amundi lifted its stake in shares of Microsoft by 30.8% in the 1st quarter. Amundi now owns 41,675,076 shares of the software giant’s stock valued at $15,426,862,000 after purchasing an additional 9,814,598 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in shares of Microsoft by 64.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 24,264,779 shares of the software giant’s stock valued at $8,982,083,000 after purchasing an additional 9,493,778 shares during the last quarter. Finally, Diamant Asset Management Inc. boosted its holdings in shares of Microsoft by 38,442.1% in the 1st quarter. Diamant Asset Management Inc. now owns 6,810,388 shares of the software giant’s stock worth $2,521,001,000 after purchasing an additional 6,792,718 shares during the period. 71.13% of the stock is currently owned by institutional investors.

Microsoft Price Performance Microsoft stock opened at $533.69 on Thursday. The firm has a market capitalization of $3.96 trillion, a price-to-earnings ratio of 29.72, a PEG ratio of 1.74 and a beta of 1.10. The company has a quick ratio of 1.22, a current ratio of 1.23 and a debt-to-equity ratio of 0.07. The company has a fifty day simple moving average of $504.15 and a 200-day simple moving average of $438.68. Microsoft Corporation has a 52-week low of $349.20 and a 52-week high of $553.72.

Microsoft (NASDAQ:MSFT – Get Free Report) last issued its earnings results on Wednesday, July 29th. The software giant reported $4.74 EPS for the quarter, topping analysts’ consensus estimates of $4.24 by $0.50. The firm had revenue of $90.01 billion during the quarter, compared to the consensus estimate of $87.62 billion. Microsoft had a net margin of 40.31% and a return on equity of 31.98%. The company’s revenue was up 17.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.65 earnings per share. On average, equities analysts anticipate that Microsoft Corporation will post 19.65 EPS for the current fiscal year. Microsoft Increases Dividend The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 10th. Stockholders of record on Thursday, November 19th will be given a dividend of $0.98 per share. This is a boost from Microsoft’s previous quarterly dividend of $0.91. The ex-dividend date of this dividend is Thursday, November 19th. This represents a $3.92 annualized dividend and a dividend yield of 0.7%. Microsoft’s dividend payout ratio is 20.27%.

Microsoft News Roundup Here are the key news stories impacting Microsoft this week:

Positive Sentiment: Microsoft unveiled its Maia 300 custom AI accelerator, designed for multi-gigawatt deployment across Azure data centers. Management says it can deliver 40% more tokens per megawatt than a GPU-based system, potentially lowering inference costs and reducing reliance on Nvidia and AMD hardware. What Could Microsoft Gain From Its Maia 300 AI Chip Rollout? Positive Sentiment: Investor optimism remains focused on Azure growth, Microsoft’s AI backlog, and more than $130 billion in reported data-center leases. The scale of commitments supports long-term demand for Azure and Copilot, although it also raises capital-spending risks. Microsoft Reports $130 Billion in Data Center Leases Positive Sentiment: Barclays raised its Microsoft price target to $600 from $512 and expects the upcoming fiscal first-quarter report to show improving differentiation in software. Earnings are scheduled for October 28. Microsoft Price Target Raised by Barclays Neutral Sentiment: Microsoft’s Azure chief reportedly seeks at least 20% cost cuts in an effort to offset soaring AI data-center expenses. The move could improve efficiency and margins, but it also highlights pressure from the company’s aggressive investment cycle. Microsoft Weighs 20% Cost Cuts in Azure Neutral Sentiment: Microsoft is introducing new AI-enabled Surface devices and an Xbox Nano Controller, supporting its broader push to put generative AI into consumer hardware. These products are strategically relevant but are unlikely to materially affect near-term results. Negative Sentiment: Hot inflation data pushed bond yields higher and triggered a broad selloff in AI-related shares, increasing concern that expensive AI infrastructure projects may face higher financing costs and tougher valuation scrutiny. Negative Sentiment: Phillip Securities downgraded Microsoft to “hold,” while Erste Group made a minor reduction to its FY2028 earnings forecast. These actions add to near-term caution following the stock’s strong run. Negative Sentiment: EVP Amy Hood sold 7,305 shares worth approximately $4.0 million under a pre-arranged Rule 10b5-1 plan. Because the sale was scheduled in advance and represents only 1.3% of her holdings, it is a limited bearish signal. Negative Sentiment: Reports that Microsoft issued security updates addressing more than 1,400 vulnerabilities could renew concerns about cybersecurity exposure, though patching the flaws is ultimately protective. Wall Street Analyst Weigh In Several research firms have recently weighed in on MSFT. Bank of America boosted their target price on Microsoft from $500.00 to $600.00 and gave the company a “buy” rating in a research report on Tuesday, September 1st. KeyCorp restated an “overweight” rating on shares of Microsoft in a report on Thursday, September 3rd. Scotiabank raised their price target on Microsoft from $510.00 to $615.00 and gave the stock an “outperform” rating in a research report on Monday, October 5th. Mizuho dropped their price objective on shares of Microsoft from $515.00 to $490.00 and set an “outperform” rating for the company in a research note on Wednesday, July 15th. Finally, Phillip Securities lowered shares of Microsoft from a “moderate buy” rating to a “hold” rating in a research note on Monday. Forty-one analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $581.24.

View Our Latest Analysis on MSFT

Insiders Place Their Bets In other Microsoft news, EVP Takeshi Numoto sold 4,810 shares of the stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $496.48, for a total value of $2,388,068.80. Following the transaction, the executive vice president directly owned 42,677 shares in the company, valued at $21,188,276.96. This represents a 10.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Judson Althoff sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 5th. The stock was sold at an average price of $487.89, for a total transaction of $4,878,900.00. Following the sale, the chief executive officer directly owned 100,447 shares in the company, valued at approximately $49,007,086.83. The trade was a 9.05% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 150,314 shares of company stock worth $75,404,992 in the last three months. 0.03% of the stock is owned by company insiders.

Microsoft Company Profile (Free Report)

Microsoft Corporation is a global technology company that develops software, cloud services, devices, gaming products and business solutions. Founded in 1975 by Bill Gates and Paul Allen, the company is best known for the Windows operating system and Microsoft Office productivity software. Microsoft is headquartered in Redmond, Washington, and serves consumers, businesses, governments and educational institutions worldwide.

Microsoft’s productivity and business offerings include Microsoft 365 applications such as Word, Excel, PowerPoint and Outlook, along with collaboration tools including Teams.

Featured Articles Five stocks we like better than Microsoft Tesla Wants to Make Its Own Chips—What Could Go Wrong? IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver? PBF Energy’s Stunning Rally Faces a Critical Test Citi Stock Falls Despite Earnings Beat: What Investors Need to Know

Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.

Avanda Investment Management Pte. Ltd. acquired a new position in shares of Microsoft Corporation (NASDAQ:MSFT – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 12,360 shares of the software giant’s stock, valued at approximately $4,611,000. Microsoft comprises 1.5% of Avanda Investment Management Pte. Ltd.’s investment portfolio, making the stock its 4th largest holding.

Several other institutional investors also recently modified their holdings of the company. Landscape Capital Management L.L.C. acquired a new position in shares of Microsoft during the second quarter worth $1,053,000. Concord Investment Counsel Inc. bought a new position in Microsoft during the 2nd quarter worth $10,742,000. Korea Investment CORP bought a new position in Microsoft during the 2nd quarter worth $1,873,752,000. EP Wealth Advisors LLC acquired a new position in Microsoft during the 2nd quarter worth about $350,329,000. Finally, Heartland Bank & Trust Co acquired a new position in Microsoft during the 2nd quarter worth about $10,934,000. 71.13% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets In other news, CEO Judson Althoff sold 10,000 shares of Microsoft stock in a transaction on Wednesday, August 5th. The shares were sold at an average price of $487.89, for a total value of $4,878,900.00. Following the completion of the sale, the chief executive officer owned 100,447 shares in the company, valued at $49,007,086.83. The trade was a 9.05% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Satya Nadella sold 86,525 shares of the business’s stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $501.46, for a total transaction of $43,388,826.50. Following the transaction, the chief executive officer owned 486,763 shares in the company, valued at $244,092,173.98. The trade was a 15.09% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 150,314 shares of company stock valued at $75,404,992 over the last 90 days. 0.03% of the stock is currently owned by corporate insiders.

Microsoft Stock Performance Shares of Microsoft stock opened at $533.69 on Thursday. The company has a current ratio of 1.23, a quick ratio of 1.22 and a debt-to-equity ratio of 0.07. The business has a 50-day moving average price of $504.15 and a two-hundred day moving average price of $438.68. Microsoft Corporation has a 1-year low of $349.20 and a 1-year high of $553.72. The company has a market cap of $3.96 trillion, a P/E ratio of 31.45, a PEG ratio of 1.74 and a beta of 1.10. Microsoft (NASDAQ:MSFT – Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The software giant reported $4.74 earnings per share for the quarter, topping the consensus estimate of $4.24 by $0.50. Microsoft had a return on equity of 31.98% and a net margin of 40.31%. The firm had revenue of $90.01 billion during the quarter, compared to analyst estimates of $87.62 billion. During the same period last year, the company posted $3.65 EPS. The business’s quarterly revenue was up 17.7% on a year-over-year basis. As a group, analysts anticipate that Microsoft Corporation will post 19.65 EPS for the current year.

Microsoft Increases Dividend The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 10th. Shareholders of record on Thursday, November 19th will be issued a dividend of $0.98 per share. This represents a $3.92 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Thursday, November 19th. This is a positive change from Microsoft’s previous quarterly dividend of $0.91. Microsoft’s dividend payout ratio (DPR) is currently 20.27%.

Analyst Ratings Changes MSFT has been the topic of a number of analyst reports. Argus reduced their price target on Microsoft from $620.00 to $510.00 and set a “buy” rating on the stock in a research report on Friday, July 10th. Jefferies Financial Group restated a “buy” rating and set a $650.00 price objective on shares of Microsoft in a research report on Wednesday. Rothschild & Co Redburn set a $440.00 price objective on Microsoft in a research note on Monday, September 21st. BNP Paribas Exane cut Microsoft from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. Finally, Guggenheim reissued a “buy” rating and set a $586.00 target price on shares of Microsoft in a research report on Monday, July 27th. Forty-one analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Microsoft has an average rating of “Moderate Buy” and an average price target of $581.24.

Read Our Latest Analysis on Microsoft

More Microsoft News Here are the key news stories impacting Microsoft this week:

Positive Sentiment: Microsoft unveiled its Maia 300 custom AI accelerator, designed for multi-gigawatt deployment across Azure data centers. Management says it can deliver 40% more tokens per megawatt than a GPU-based system, potentially lowering inference costs and reducing reliance on Nvidia and AMD hardware. What Could Microsoft Gain From Its Maia 300 AI Chip Rollout? Positive Sentiment: Investor optimism remains focused on Azure growth, Microsoft’s AI backlog, and more than $130 billion in reported data-center leases. The scale of commitments supports long-term demand for Azure and Copilot, although it also raises capital-spending risks. Microsoft Reports $130 Billion in Data Center Leases Positive Sentiment: Barclays raised its Microsoft price target to $600 from $512 and expects the upcoming fiscal first-quarter report to show improving differentiation in software. Earnings are scheduled for October 28. Microsoft Price Target Raised by Barclays Neutral Sentiment: Microsoft’s Azure chief reportedly seeks at least 20% cost cuts in an effort to offset soaring AI data-center expenses. The move could improve efficiency and margins, but it also highlights pressure from the company’s aggressive investment cycle. Microsoft Weighs 20% Cost Cuts in Azure Neutral Sentiment: Microsoft is introducing new AI-enabled Surface devices and an Xbox Nano Controller, supporting its broader push to put generative AI into consumer hardware. These products are strategically relevant but are unlikely to materially affect near-term results. Negative Sentiment: Hot inflation data pushed bond yields higher and triggered a broad selloff in AI-related shares, increasing concern that expensive AI infrastructure projects may face higher financing costs and tougher valuation scrutiny. Negative Sentiment: Phillip Securities downgraded Microsoft to “hold,” while Erste Group made a minor reduction to its FY2028 earnings forecast. These actions add to near-term caution following the stock’s strong run. Negative Sentiment: EVP Amy Hood sold 7,305 shares worth approximately $4.0 million under a pre-arranged Rule 10b5-1 plan. Because the sale was scheduled in advance and represents only 1.3% of her holdings, it is a limited bearish signal. Negative Sentiment: Reports that Microsoft issued security updates addressing more than 1,400 vulnerabilities could renew concerns about cybersecurity exposure, though patching the flaws is ultimately protective. Microsoft Profile (Free Report)

Microsoft Corporation is a global technology company that develops software, cloud services, devices, gaming products and business solutions. Founded in 1975 by Bill Gates and Paul Allen, the company is best known for the Windows operating system and Microsoft Office productivity software. Microsoft is headquartered in Redmond, Washington, and serves consumers, businesses, governments and educational institutions worldwide.

Microsoft’s productivity and business offerings include Microsoft 365 applications such as Word, Excel, PowerPoint and Outlook, along with collaboration tools including Teams.

Featured Articles Five stocks we like better than Microsoft Tesla Wants to Make Its Own Chips—What Could Go Wrong? IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver? PBF Energy’s Stunning Rally Faces a Critical Test Citi Stock Falls Despite Earnings Beat: What Investors Need to Know

Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.

SummaryAlibaba Group Holding Limited is down 41% from its 2025 peak as earnings recovery lags and capex expectations rise, but profitability recovery remains plausible.Q1 revenue grew 9% YoY, driven by China Quick Commerce and Cloud (+45% each), while traditional e-commerce declined and AI investments increased cash burn.Alibaba's investment case is shifting from mature e-commerce to high-margin cloud ambitions, targeting 20 GW data center power and 1 trillion RMB cloud revenue by 2032.Despite high capex needs (200–300bn RMB/year), Alibaba's strong balance sheet, low valuation (PEG 0.61), and potential for margin normalization offer significant upside. maybefalse/iStock Unreleased via Getty Images

Investment Summary The stock price of Alibaba Group Holding Limited (BABA) is down 41% from its peak in 2025 as earnings recovery takes longer than expected and the CapEx expectations pile up. However, the company path

30 Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

First Citizens Bank & Trust Co. lifted its position in shares of Citigroup Inc. (NYSE:C – Free Report) by 112.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 31,096 shares of the company’s stock after acquiring an additional 16,484 shares during the period. First Citizens Bank & Trust Co.’s holdings in Citigroup were worth $4,026,000 as of its most recent filing with the SEC.

Several other large investors have also recently added to or reduced their stakes in the business. State Street Corp lifted its holdings in shares of Citigroup by 3.7% during the second quarter. State Street Corp now owns 80,956,349 shares of the company’s stock valued at $11,199,986,000 after purchasing an additional 2,913,701 shares during the last quarter. Bank of New York Mellon Corp acquired a new stake in shares of Citigroup during the 2nd quarter valued at $3,244,602,000. Bank of America Corp DE grew its stake in Citigroup by 2.8% in the first quarter. Bank of America Corp DE now owns 26,869,012 shares of the company’s stock valued at $3,047,215,000 after purchasing an additional 728,043 shares in the last quarter. Invesco Ltd. increased its holdings in Citigroup by 6.2% in the fourth quarter. Invesco Ltd. now owns 15,139,403 shares of the company’s stock worth $1,766,617,000 after buying an additional 887,430 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Citigroup by 10.7% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 12,467,857 shares of the company’s stock valued at $1,745,001,000 after purchasing an additional 1,210,006 shares in the last quarter. 71.72% of the stock is currently owned by institutional investors and hedge funds.

More Citigroup News Here are the key news stories impacting Citigroup this week:

Positive Sentiment: Citigroup reported third-quarter earnings of $2.85 per share, above the roughly $2.65 analyst consensus, while revenue rose 7.9% year over year to approximately $23.85 billion. Net income increased 40% to $5.2 billion, supported by growth in Services, Wealth and Markets. Citi profit jumps 40% with higher investment banking, services and wealth revenue Positive Sentiment: Management raised its 2026 profitability outlook, citing strong Services growth, AI-driven efficiency gains and disciplined capital deployment. Citi also increased shareholder returns through dividends and share repurchases, with approximately $4.1 billion returned during the quarter. Citigroup Q3 Earnings Call Highlights Higher Return Outlook and AI Gains Positive Sentiment: Loan growth and deposits remained healthy, while Citi’s fixed-income trading results were stronger than expected. These trends support the bank’s turnaround and restructuring efforts. Neutral Sentiment: Royal Bank of Canada lowered its price target from $150 to $135 but maintained an “Outperform” rating, implying potential upside from recent levels. RBC lowers Citigroup price target Negative Sentiment: Investors questioned how durable the beat was because trading and investment-banking gains may cool from unusually strong prior-quarter levels. Management also indicated that fourth-quarter trading revenue could decline sharply, while deal activity has moderated. Citi Stock Falls Despite Earnings Beat Negative Sentiment: Higher credit-loss provisions, rising reserves, a flat U.S. card business and concerns about capital ratios added to investor caution. Several analysts subsequently reduced their price targets or downgraded the stock to Hold. Negative Sentiment: Unusually heavy put-option activity and elevated Treasury yields are reinforcing a cautious view of bank stocks. Regulatory scrutiny of large banks’ “debanking” practices is an additional potential overhang for Citigroup. Citigroup Trading Down 1.6% Shares of Citigroup stock opened at $122.53 on Thursday. Citigroup Inc. has a 52-week low of $95.00 and a 52-week high of $147.96. The firm has a 50-day moving average of $133.16 and a 200-day moving average of $131.71. The stock has a market cap of $208.99 billion, a PE ratio of 11.95, a PEG ratio of 0.55 and a beta of 1.13. The company has a debt-to-equity ratio of 1.78, a quick ratio of 0.99 and a current ratio of 1.00. Citigroup (NYSE:C – Get Free Report) last posted its earnings results on Tuesday, October 13th. The company reported $2.85 earnings per share for the quarter, topping analysts’ consensus estimates of $2.66 by $0.19. The firm had revenue of $23.84 billion for the quarter, compared to analysts’ expectations of $23.74 billion. Citigroup had a net margin of 10.97% and a return on equity of 10.57%. The company’s revenue was up 7.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.86 earnings per share. As a group, sell-side analysts forecast that Citigroup Inc. will post 11.19 EPS for the current year.

Citigroup Increases Dividend The company also recently disclosed a quarterly dividend, which was paid on Friday, August 28th. Shareholders of record on Monday, August 3rd were paid a $0.67 dividend. This is a positive change from Citigroup’s previous quarterly dividend of $0.60. The ex-dividend date was Monday, August 3rd. This represents a $2.68 annualized dividend and a yield of 2.2%. Citigroup’s dividend payout ratio (DPR) is 28.94%.

Analyst Upgrades and Downgrades Several research analysts have commented on C shares. Wells Fargo & Company lifted their price target on Citigroup from $162.00 to $165.00 and gave the stock an “overweight” rating in a research report on Thursday, June 18th. Bank of America upped their price objective on Citigroup from $170.00 to $176.00 and gave the company a “buy” rating in a research note on Tuesday, July 7th. Argus set a $150.00 price target on shares of Citigroup in a report on Wednesday, July 15th. HSBC began coverage on Citigroup in a report on Monday, September 28th. They set a “buy” rating and a $164.00 target price on the stock. Finally, JPMorgan Chase & Co. lowered their price target on shares of Citigroup from $149.00 to $147.00 and set an “overweight” rating for the company in a report on Friday, October 2nd. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Citigroup presently has an average rating of “Moderate Buy” and an average price target of $150.79.

View Our Latest Stock Report on C

Citigroup Company Profile (Free Report)

Citigroup Inc is a global financial services company headquartered in New York City and listed on the New York Stock Exchange under the symbol C. Through its subsidiaries and businesses, Citi provides banking, lending, investment, payments, wealth management and other financial services to consumers, businesses, governments and institutional clients.

Citi’s principal businesses include Services, which supports institutional clients with treasury, trade, securities services and related solutions; Markets, which provides sales, trading, research and financing services; Banking, which offers investment banking and corporate banking; and Wealth, which provides private banking and wealth management.

See Also Five stocks we like better than Citigroup Tesla Wants to Make Its Own Chips—What Could Go Wrong? IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver? PBF Energy’s Stunning Rally Faces a Critical Test Citi Stock Falls Despite Earnings Beat: What Investors Need to Know

Receive News & Ratings for Citigroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Citigroup and related companies with MarketBeat.com's FREE daily email newsletter.

Livforsakringsbolaget Skandia Omsesidigt lifted its stake in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 0.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,347,275 shares of the computer hardware maker’s stock after purchasing an additional 9,900 shares during the period. NVIDIA makes up about 8.7% of Livforsakringsbolaget Skandia Omsesidigt’s investment portfolio, making the stock its biggest position. Livforsakringsbolaget Skandia Omsesidigt’s holdings in NVIDIA were worth $269,132,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of NVDA. J. Stern & Co. LLP raised its holdings in NVIDIA by 13,709.1% during the 4th quarter. J. Stern & Co. LLP now owns 125,760,307 shares of the computer hardware maker’s stock worth $23,454,297,000 after purchasing an additional 124,849,603 shares during the last quarter. Jupiter Topco LLC acquired a new position in NVIDIA during the 2nd quarter valued at about $16,156,076,000. Amundi boosted its stake in shares of NVIDIA by 10.4% in the 1st quarter. Amundi now owns 133,768,018 shares of the computer hardware maker’s stock valued at $23,329,141,000 after purchasing an additional 12,575,177 shares during the last quarter. SEB Asset Management AB bought a new position in shares of NVIDIA in the 1st quarter valued at about $1,692,807,000. Finally, Employees Provident Fund Board bought a new position in shares of NVIDIA in the 4th quarter valued at about $1,243,336,000. 65.27% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes A number of equities analysts have issued reports on the stock. BMO Capital Markets set a $340.00 price objective on shares of NVIDIA and gave the company an “outperform” rating in a research note on Thursday, August 20th. KGI Securities lifted their target price on shares of NVIDIA from $335.00 to $345.00 in a report on Thursday, August 27th. Itau BBA Securities dropped their target price on shares of NVIDIA from $256.00 to $218.00 in a research report on Wednesday, June 24th. Truist Financial increased their price target on NVIDIA from $307.00 to $346.00 and gave the company a “buy” rating in a research note on Thursday, August 27th. Finally, TD Cowen reissued a “buy” rating on shares of NVIDIA in a research note on Tuesday, August 18th. Five analysts have rated the stock with a Strong Buy rating, forty-nine have issued a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $321.89.

View Our Latest Report on NVDA Insiders Place Their Bets In other NVIDIA news, Director Mark Stevens sold 622,239 shares of NVIDIA stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $231.62, for a total value of $144,122,997.18. Following the transaction, the director owned 2,336,531 shares in the company, valued at $541,187,310.22. The trade was a 21.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Colette Kress sold 34,918 shares of the company’s stock in a transaction on Thursday, September 17th. The stock was sold at an average price of $219.05, for a total transaction of $7,648,787.90. Following the transaction, the chief financial officer owned 765,103 shares of the company’s stock, valued at $167,595,812.15. This trade represents a 4.36% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,766,118 shares of company stock worth $399,450,353 over the last three months. Insiders own 3.94% of the company’s stock.

NVIDIA Stock Down 3.2% Shares of NVDA stock opened at $221.30 on Thursday. NVIDIA Corporation has a 52-week low of $164.27 and a 52-week high of $243.37. The stock has a market cap of $5.33 trillion, a price-to-earnings ratio of 27.98, a PEG ratio of 1.77 and a beta of 2.22. The firm’s 50-day moving average is $223.43 and its 200-day moving average is $210.73. The company has a debt-to-equity ratio of 0.14, a quick ratio of 3.85 and a current ratio of 4.59.

NVIDIA (NASDAQ:NVDA – Get Free Report) last announced its earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 EPS for the quarter, topping the consensus estimate of $2.09 by $0.13. NVIDIA had a net margin of 63.66% and a return on equity of 96.04%. The business had revenue of $96.22 billion during the quarter, compared to the consensus estimate of $92.27 billion. During the same quarter in the previous year, the firm posted $1.05 EPS. NVIDIA’s revenue was up 105.9% compared to the same quarter last year. Sell-side analysts predict that NVIDIA Corporation will post 9.25 EPS for the current year.

NVIDIA Dividend Announcement The firm also recently announced a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Thursday, September 10th were paid a dividend of $0.25 per share. The ex-dividend date was Thursday, September 10th. This represents a $1.00 annualized dividend and a yield of 0.5%. NVIDIA’s dividend payout ratio is presently 12.64%.

NVIDIA declared that its board has initiated a share repurchase program on Monday, September 28th that allows the company to buy back $150.00 billion in shares. This buyback authorization allows the computer hardware maker to repurchase up to 2.8% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s management believes its stock is undervalued.

Key NVIDIA News Here are the key news stories impacting NVIDIA this week:

Positive Sentiment: NVIDIA announced a five-year, $250 million compute commitment to support U.K. AI safety and security research. The initiative strengthens NVIDIA’s relationships with governments, universities and AI developers while promoting its hardware and software ecosystem. NVIDIA pledges $250 million to boost UK AI safety research Positive Sentiment: New ecosystem announcements highlighted continued demand for NVIDIA technology. LSEG is using NVIDIA GPUs to accelerate historical market-data processing, while NVIDIA introduced tools including cuPotential for molecular simulation and expanded collaborations in AI-defined chip manufacturing. LSEG teams up with NVIDIA for faster market data processing Positive Sentiment: State Street launched a sector ETF designed to give NVIDIA a 20.93% allocation, above the 15.41% weighting in its comparable fund, potentially creating incremental demand for NVDA shares. New State Street Sector ETFs Give Biggest Stocks Full Weight Neutral Sentiment: CEO Jensen Huang said NVIDIA would stop supplying chips to customers developing unsafe AI systems. The stance may improve regulatory and reputational positioning, although broader AI-safety concerns could increase scrutiny of the company and industry. Nvidia, Anthropic Weigh In On AI Safeguards Negative Sentiment: Investors are assessing competitive threats from Microsoft’s Maia 300 architecture and Intel’s lower-cost, air-cooled Crescent Island inference GPU. Custom accelerators and cheaper inference solutions could pressure NVIDIA’s pricing, growth assumptions and market share over time. Microsoft Just Unveiled a Brand-New AI Chip Negative Sentiment: IDC reportedly estimates NVIDIA’s China AI-chip market share has fallen to 34% as Huawei gains ground, underscoring export restrictions and rising local competition. Separately, investor Michael Burry is betting against chip stocks, reinforcing valuation and AI-spending concerns. NVIDIA’s China AI chip market share falls to 34% About NVIDIA (Free Report)

NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.

The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.

Read More Five stocks we like better than NVIDIA Tesla Wants to Make Its Own Chips—What Could Go Wrong? IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver? PBF Energy’s Stunning Rally Faces a Critical Test Citi Stock Falls Despite Earnings Beat: What Investors Need to Know Want to see what other hedge funds are holding NVDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NVIDIA Corporation (NASDAQ:NVDA – Free Report).

Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.

Rakuten Investment Management Inc. lifted its holdings in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 12.4% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,767,757 shares of the computer hardware maker’s stock after purchasing an additional 527,365 shares during the period. NVIDIA accounts for 2.7% of Rakuten Investment Management Inc.’s holdings, making the stock its 5th biggest holding. Rakuten Investment Management Inc.’s holdings in NVIDIA were worth $929,570,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of NVDA. Boyd Wealth Management LLC increased its holdings in shares of NVIDIA by 273.4% during the second quarter. Boyd Wealth Management LLC now owns 9,145 shares of the computer hardware maker’s stock valued at $1,830,000 after acquiring an additional 6,696 shares in the last quarter. Ally Financial Inc. lifted its holdings in shares of NVIDIA by 10.3% in the 2nd quarter. Ally Financial Inc. now owns 172,000 shares of the computer hardware maker’s stock worth $34,415,000 after purchasing an additional 16,000 shares in the last quarter. Altshuler Shaham Ltd grew its position in NVIDIA by 6,451.9% in the 1st quarter. Altshuler Shaham Ltd now owns 637,236 shares of the computer hardware maker’s stock valued at $111,134,000 after purchasing an additional 627,510 shares during the period. Storen Legacy Partners LLC acquired a new stake in NVIDIA in the 4th quarter valued at $1,350,000. Finally, Baker Tilly Wealth Management LLC grew its position in NVIDIA by 7.4% in the 2nd quarter. Baker Tilly Wealth Management LLC now owns 71,898 shares of the computer hardware maker’s stock valued at $14,386,000 after purchasing an additional 4,958 shares during the period. Institutional investors own 65.27% of the company’s stock.

More NVIDIA News Here are the key news stories impacting NVIDIA this week:

Positive Sentiment: NVIDIA announced a five-year, $250 million compute commitment to support U.K. AI safety and security research. The initiative strengthens NVIDIA’s relationships with governments, universities and AI developers while promoting its hardware and software ecosystem. NVIDIA pledges $250 million to boost UK AI safety research Positive Sentiment: New ecosystem announcements highlighted continued demand for NVIDIA technology. LSEG is using NVIDIA GPUs to accelerate historical market-data processing, while NVIDIA introduced tools including cuPotential for molecular simulation and expanded collaborations in AI-defined chip manufacturing. LSEG teams up with NVIDIA for faster market data processing Positive Sentiment: State Street launched a sector ETF designed to give NVIDIA a 20.93% allocation, above the 15.41% weighting in its comparable fund, potentially creating incremental demand for NVDA shares. New State Street Sector ETFs Give Biggest Stocks Full Weight Neutral Sentiment: CEO Jensen Huang said NVIDIA would stop supplying chips to customers developing unsafe AI systems. The stance may improve regulatory and reputational positioning, although broader AI-safety concerns could increase scrutiny of the company and industry. Nvidia, Anthropic Weigh In On AI Safeguards Negative Sentiment: Investors are assessing competitive threats from Microsoft’s Maia 300 architecture and Intel’s lower-cost, air-cooled Crescent Island inference GPU. Custom accelerators and cheaper inference solutions could pressure NVIDIA’s pricing, growth assumptions and market share over time. Microsoft Just Unveiled a Brand-New AI Chip Negative Sentiment: IDC reportedly estimates NVIDIA’s China AI-chip market share has fallen to 34% as Huawei gains ground, underscoring export restrictions and rising local competition. Separately, investor Michael Burry is betting against chip stocks, reinforcing valuation and AI-spending concerns. NVIDIA’s China AI chip market share falls to 34% NVIDIA Trading Down 3.2% NVIDIA stock opened at $221.30 on Thursday. The company has a debt-to-equity ratio of 0.14, a quick ratio of 3.85 and a current ratio of 4.59. NVIDIA Corporation has a fifty-two week low of $164.27 and a fifty-two week high of $243.37. The stock has a market cap of $5.33 trillion, a P/E ratio of 27.98, a PEG ratio of 1.77 and a beta of 2.22. The firm’s fifty day moving average price is $223.43 and its 200-day moving average price is $210.73. NVIDIA (NASDAQ:NVDA – Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The computer hardware maker reported $2.22 EPS for the quarter, beating the consensus estimate of $2.09 by $0.13. NVIDIA had a return on equity of 96.04% and a net margin of 63.66%. The firm had revenue of $96.22 billion for the quarter, compared to analyst estimates of $92.27 billion. During the same period in the prior year, the company earned $1.05 EPS. The company’s revenue was up 105.9% on a year-over-year basis. Equities research analysts forecast that NVIDIA Corporation will post 9.25 earnings per share for the current fiscal year.

NVIDIA declared that its board has authorized a share buyback program on Monday, September 28th that permits the company to repurchase $150.00 billion in shares. This repurchase authorization permits the computer hardware maker to buy up to 2.8% of its shares through open market purchases. Stock repurchase programs are usually an indication that the company’s management believes its shares are undervalued.

NVIDIA Dividend Announcement The firm also recently announced a quarterly dividend, which was paid on Thursday, October 1st. Investors of record on Thursday, September 10th were issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Thursday, September 10th. NVIDIA’s dividend payout ratio is currently 12.64%.

Insider Activity at NVIDIA In other NVIDIA news, EVP Timothy S. Teter sold 30,460 shares of NVIDIA stock in a transaction on Monday, September 21st. The stock was sold at an average price of $222.80, for a total transaction of $6,786,488.00. Following the completion of the transaction, the executive vice president owned 2,687,660 shares in the company, valued at approximately $598,810,648. The trade was a 1.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Colette Kress sold 34,918 shares of the firm’s stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $219.05, for a total transaction of $7,648,787.90. Following the sale, the chief financial officer directly owned 765,103 shares of the company’s stock, valued at $167,595,812.15. This trade represents a 4.36% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,766,118 shares of company stock worth $399,450,353 over the last quarter. 3.94% of the stock is owned by corporate insiders.

Analysts Set New Price Targets Several brokerages recently issued reports on NVDA. DA Davidson reaffirmed a “buy” rating and set a $300.00 target price on shares of NVIDIA in a research report on Thursday, August 27th. Rosenblatt Securities reissued a “buy” rating and issued a $390.00 price target on shares of NVIDIA in a report on Tuesday, September 29th. Wedbush increased their price target on shares of NVIDIA from $330.00 to $345.00 and gave the company an “outperform” rating in a research report on Thursday, August 27th. Benchmark restated a “buy” rating and set a $335.00 price objective on shares of NVIDIA in a report on Thursday, August 27th. Finally, UBS Group reaffirmed a “buy” rating on shares of NVIDIA in a research report on Friday, October 9th. Five research analysts have rated the stock with a Strong Buy rating, forty-nine have issued a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $321.89.

Get Our Latest Stock Report on NVDA

About NVIDIA (Free Report)

NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.

The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.

Featured Articles Five stocks we like better than NVIDIA Tesla Wants to Make Its Own Chips—What Could Go Wrong? IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver? PBF Energy’s Stunning Rally Faces a Critical Test Citi Stock Falls Despite Earnings Beat: What Investors Need to Know Want to see what other hedge funds are holding NVDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NVIDIA Corporation (NASDAQ:NVDA – Free Report).

Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.

RIHO Partners LLC raised its holdings in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 32.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 86,461 shares of the computer hardware maker’s stock after buying an additional 21,127 shares during the period. NVIDIA comprises approximately 9.7% of RIHO Partners LLC’s investment portfolio, making the stock its 5th biggest position. RIHO Partners LLC’s holdings in NVIDIA were worth $17,300,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of NVDA. Lifetime Wealth Management P.C. bought a new stake in shares of NVIDIA during the fourth quarter worth $26,000. Longview Financial Advisors Inc. purchased a new stake in shares of NVIDIA during the first quarter valued at $27,000. Langley Wealth Management LLC bought a new position in shares of NVIDIA in the second quarter worth about $34,000. Phillip James Consulting Co. bought a new position in shares of NVIDIA in the first quarter worth about $40,000. Finally, Bard Associates Inc. grew its holdings in shares of NVIDIA by 8,866.7% in the second quarter. Bard Associates Inc. now owns 269 shares of the computer hardware maker’s stock worth $54,000 after purchasing an additional 266 shares during the last quarter. Institutional investors own 65.27% of the company’s stock.

Key NVIDIA News Here are the key news stories impacting NVIDIA this week:

Positive Sentiment: NVIDIA announced a five-year, $250 million compute commitment to support U.K. AI safety and security research. The initiative strengthens NVIDIA’s relationships with governments, universities and AI developers while promoting its hardware and software ecosystem. NVIDIA pledges $250 million to boost UK AI safety research Positive Sentiment: New ecosystem announcements highlighted continued demand for NVIDIA technology. LSEG is using NVIDIA GPUs to accelerate historical market-data processing, while NVIDIA introduced tools including cuPotential for molecular simulation and expanded collaborations in AI-defined chip manufacturing. LSEG teams up with NVIDIA for faster market data processing Positive Sentiment: State Street launched a sector ETF designed to give NVIDIA a 20.93% allocation, above the 15.41% weighting in its comparable fund, potentially creating incremental demand for NVDA shares. New State Street Sector ETFs Give Biggest Stocks Full Weight Neutral Sentiment: CEO Jensen Huang said NVIDIA would stop supplying chips to customers developing unsafe AI systems. The stance may improve regulatory and reputational positioning, although broader AI-safety concerns could increase scrutiny of the company and industry. Nvidia, Anthropic Weigh In On AI Safeguards Negative Sentiment: Investors are assessing competitive threats from Microsoft’s Maia 300 architecture and Intel’s lower-cost, air-cooled Crescent Island inference GPU. Custom accelerators and cheaper inference solutions could pressure NVIDIA’s pricing, growth assumptions and market share over time. Microsoft Just Unveiled a Brand-New AI Chip Negative Sentiment: IDC reportedly estimates NVIDIA’s China AI-chip market share has fallen to 34% as Huawei gains ground, underscoring export restrictions and rising local competition. Separately, investor Michael Burry is betting against chip stocks, reinforcing valuation and AI-spending concerns. NVIDIA’s China AI chip market share falls to 34% Insider Buying and Selling at NVIDIA In other news, CFO Colette Kress sold 34,918 shares of the firm’s stock in a transaction dated Thursday, September 17th. The shares were sold at an average price of $219.05, for a total value of $7,648,787.90. Following the transaction, the chief financial officer directly owned 765,103 shares of the company’s stock, valued at approximately $167,595,812.15. This trade represents a 4.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Timothy S. Teter sold 30,460 shares of the company’s stock in a transaction that occurred on Monday, September 21st. The shares were sold at an average price of $222.80, for a total value of $6,786,488.00. Following the completion of the sale, the executive vice president owned 2,687,660 shares of the company’s stock, valued at $598,810,648. This trade represents a 1.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 1,766,118 shares of company stock worth $399,450,353. Corporate insiders own 3.94% of the company’s stock. NVIDIA Stock Performance Shares of NVDA stock opened at $221.30 on Thursday. The firm has a market capitalization of $5.33 trillion, a price-to-earnings ratio of 27.98, a price-to-earnings-growth ratio of 1.77 and a beta of 2.22. The company has a debt-to-equity ratio of 0.14, a current ratio of 4.59 and a quick ratio of 3.85. The business has a fifty day moving average of $223.43 and a 200 day moving average of $210.73. NVIDIA Corporation has a 1 year low of $164.27 and a 1 year high of $243.37.

NVIDIA (NASDAQ:NVDA – Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.09 by $0.13. NVIDIA had a return on equity of 96.04% and a net margin of 63.66%. The business had revenue of $96.22 billion during the quarter, compared to analysts’ expectations of $92.27 billion. During the same quarter in the previous year, the firm posted $1.05 EPS. The company’s revenue for the quarter was up 105.9% on a year-over-year basis. As a group, research analysts expect that NVIDIA Corporation will post 9.25 earnings per share for the current year.

NVIDIA declared that its board has approved a share repurchase plan on Monday, September 28th that allows the company to buy back $150.00 billion in shares. This repurchase authorization allows the computer hardware maker to purchase up to 2.8% of its shares through open market purchases. Stock repurchase plans are generally an indication that the company’s leadership believes its stock is undervalued.

NVIDIA Announces Dividend The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 1st. Investors of record on Thursday, September 10th were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend was Thursday, September 10th. NVIDIA’s dividend payout ratio is currently 12.64%.

Wall Street Analyst Weigh In A number of brokerages recently issued reports on NVDA. Oppenheimer set a $315.00 price target on NVIDIA and gave the company an “outperform” rating in a report on Thursday, August 27th. Cantor Fitzgerald reissued an “overweight” rating and issued a $350.00 price objective on shares of NVIDIA in a research note on Thursday, October 1st. TD Cowen restated a “buy” rating on shares of NVIDIA in a report on Tuesday, August 18th. BNP Paribas Exane reaffirmed an “outperform” rating and set a $345.00 target price on shares of NVIDIA in a research report on Monday, October 5th. Finally, UBS Group reaffirmed a “buy” rating on shares of NVIDIA in a research report on Friday, October 9th. Five investment analysts have rated the stock with a Strong Buy rating, forty-nine have given a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy” and an average price target of $321.89.

Check Out Our Latest Research Report on NVIDIA

About NVIDIA (Free Report)

NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.

The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.

Featured Articles Five stocks we like better than NVIDIA Tesla Wants to Make Its Own Chips—What Could Go Wrong? IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver? PBF Energy’s Stunning Rally Faces a Critical Test Citi Stock Falls Despite Earnings Beat: What Investors Need to Know Want to see what other hedge funds are holding NVDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NVIDIA Corporation (NASDAQ:NVDA – Free Report).

Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.

First Citizens Bank & Trust Co. lifted its stake in shares of JPMorgan Chase & Co. (NYSE:JPM) by 18.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 136,045 shares of the financial services provider’s stock after buying an additional 21,441 shares during the period. JPMorgan Chase & Co. makes up approximately 0.6% of First Citizens Bank & Trust Co.’s investment portfolio, making the stock its 27th biggest holding. First Citizens Bank & Trust Co.’s holdings in JPMorgan Chase & Co. were worth $45,008,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. E Fund Management Co. Ltd. boosted its position in JPMorgan Chase & Co. by 7.1% in the second quarter. E Fund Management Co. Ltd. now owns 29,956 shares of the financial services provider’s stock valued at $9,805,000 after buying an additional 1,973 shares during the last quarter. Edmond DE Rothschild Holding S.A. lifted its holdings in shares of JPMorgan Chase & Co. by 4.6% in the 2nd quarter. Edmond DE Rothschild Holding S.A. now owns 343,644 shares of the financial services provider’s stock valued at $112,485,000 after buying an additional 15,017 shares during the period. First National Bank of Mount Dora Trust Investment Services lifted its holdings in JPMorgan Chase & Co. by 18.7% in the first quarter. First National Bank of Mount Dora Trust Investment Services now owns 41,218 shares of the financial services provider’s stock valued at $12,125,000 after acquiring an additional 6,492 shares during the period. FAS Wealth Partners Inc. increased its holdings in shares of JPMorgan Chase & Co. by 4.3% during the 1st quarter. FAS Wealth Partners Inc. now owns 43,527 shares of the financial services provider’s stock valued at $12,804,000 after purchasing an additional 1,794 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. raised its position in shares of JPMorgan Chase & Co. by 2.9% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,170,524 shares of the financial services provider’s stock worth $383,148,000 after acquiring an additional 33,071 shares during the period. 71.55% of the stock is currently owned by institutional investors and hedge funds.

More JPMorgan Chase & Co. News Here are the key news stories impacting JPMorgan Chase & Co. this week:

Positive Sentiment: Management projected approximately $107 billion in 2027 net interest income, excluding Markets, implying continued growth from fourth-quarter guidance. Resilient consumer activity, asset inflows and strength across investment banking and commercial banking supported the outlook. JPMorgan Q3 Earnings Call Highlights Capital Deployment and AI Risks Positive Sentiment: Analysts raised their price targets despite the results. Morgan Stanley lifted its target to $377 while maintaining an Equal Weight rating, and RBC reaffirmed Outperform with a $370 target. These revisions indicate that analysts view the earnings shortfall as manageable. JPMorgan Analysts Boost Their Forecasts After Q3 Results Positive Sentiment: Third-quarter revenue rose about 8% year over year to roughly $50.2 billion, while net income increased 6%. Consumer & Community Banking, the Commercial & Investment Bank and Asset & Wealth Management all posted year-over-year profit growth. JPMorgan Chase Reports $15.3 Billion Third-Quarter Net Income Neutral Sentiment: JPMorgan is restricting unvetted external AI agents from directly accessing customer accounts and is developing internal defensive tools. The policy limits near-term AI disruption and security exposure, but could increase technology and compliance costs. JPMorgan Chase blocks outside AI agents Negative Sentiment: Adjusted earnings of $5.75 per share missed the $5.94 consensus estimate, while revenue also fell short of expectations. Lower fixed-income trading revenue, investment-securities losses and softer dealmaking weighed on results. JPMorgan Earnings Miss Estimates But Reveal Broad-Based Strength Negative Sentiment: CEO Jamie Dimon warned that prolonged high interest rates could weaken consumer credit and that the probability of a market shock is higher than many investors assume. A flattening yield curve, inflation and elevated fiscal deficits remain additional risks to future bank profitability. Jamie Dimon Sees Higher Chance of Market Trouble Analysts Set New Price Targets Several equities analysts recently weighed in on JPM shares. Zacks Research lowered JPMorgan Chase & Co. from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 14th. Weiss Ratings raised JPMorgan Chase & Co. from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Friday, October 9th. Citigroup upped their target price on JPMorgan Chase & Co. from $325.00 to $360.00 and gave the stock a “neutral” rating in a research note on Monday, July 20th. Royal Bank Of Canada reiterated an “outperform” rating and set a $370.00 target price on shares of JPMorgan Chase & Co. in a research report on Wednesday. Finally, UBS Group dropped their price target on shares of JPMorgan Chase & Co. from $400.00 to $395.00 and set a “buy” rating on the stock in a research note on Monday, October 5th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and thirteen have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $365.04. View Our Latest Analysis on JPMorgan Chase & Co.

JPMorgan Chase & Co. Price Performance NYSE:JPM opened at $335.03 on Thursday. The stock has a 50 day moving average of $349.00 and a two-hundred day moving average of $329.80. JPMorgan Chase & Co. has a 12 month low of $279.10 and a 12 month high of $366.50. The firm has a market cap of $890.58 billion, a P/E ratio of 14.05, a price-to-earnings-growth ratio of 1.36 and a beta of 1.02. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 1.31.

JPMorgan Chase & Co. (NYSE:JPM – Get Free Report) last released its earnings results on Tuesday, October 13th. The financial services provider reported $5.75 earnings per share for the quarter, missing the consensus estimate of $5.94 by ($0.19). The firm had revenue of $50.17 billion during the quarter, compared to analysts’ expectations of $51.23 billion. JPMorgan Chase & Co. had a net margin of 21.85% and a return on equity of 18.48%. The business’s revenue was up 8.1% compared to the same quarter last year. During the same quarter last year, the business earned $5.07 EPS. On average, analysts expect that JPMorgan Chase & Co. will post 24.18 earnings per share for the current fiscal year.

JPMorgan Chase & Co. Increases Dividend The company also recently disclosed a quarterly dividend, which will be paid on Saturday, October 31st. Investors of record on Tuesday, October 6th will be paid a $1.65 dividend. The ex-dividend date of this dividend is Tuesday, October 6th. This represents a $6.60 annualized dividend and a yield of 2.0%. This is an increase from JPMorgan Chase & Co.’s previous quarterly dividend of $1.50. JPMorgan Chase & Co.’s dividend payout ratio is currently 28.28%.

Insider Buying and Selling In related news, insider Robin Leopold sold 2,500 shares of the stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $352.81, for a total value of $882,025.00. Following the completion of the transaction, the insider directly owned 71,047 shares of the company’s stock, valued at approximately $25,066,092.07. This represents a 3.40% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.41% of the company’s stock.

JPMorgan Chase & Co. Profile (Free Report)

JPMorgan Chase & Co is a global financial services company headquartered in New York City. Through its businesses, the company provides banking, investment banking, asset management, private banking, commercial banking, consumer lending and payment services to individuals, businesses, institutions and governments.

The company operates through major business areas that include Consumer & Community Banking, Commercial & Investment Banking, and Asset & Wealth Management. Its products and services include deposit accounts, credit cards, mortgages, auto loans, business financing, investment and advisory services, securities trading and custody, payment processing, and wealth-management solutions.

JPMorgan Chase serves customers in the United States and maintains operations and client relationships across international markets.

Read More Five stocks we like better than JPMorgan Chase & Co. Tesla Wants to Make Its Own Chips—What Could Go Wrong? IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver? PBF Energy’s Stunning Rally Faces a Critical Test Citi Stock Falls Despite Earnings Beat: What Investors Need to Know Want to see what other hedge funds are holding JPM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan Chase & Co. (NYSE:JPM – Free Report).

Receive News & Ratings for JPMorgan Chase & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan Chase & Co. and related companies with MarketBeat.com's FREE daily email newsletter.

NorthCrest Asset Manangement LLC grew its holdings in shares of Altria Group, Inc. (NYSE:MO – Free Report) by 201.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 22,340 shares of the company’s stock after acquiring an additional 14,928 shares during the period. NorthCrest Asset Manangement LLC’s holdings in Altria Group were worth $1,596,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Cornerstone Planning Group LLC increased its position in Altria Group by 5.8% in the 1st quarter. Cornerstone Planning Group LLC now owns 2,619 shares of the company’s stock valued at $191,000 after buying an additional 143 shares in the last quarter. Angeles Wealth Management LLC lifted its stake in Altria Group by 1.3% during the 2nd quarter. Angeles Wealth Management LLC now owns 11,239 shares of the company’s stock valued at $821,000 after acquiring an additional 146 shares in the last quarter. Bernardo Wealth Planning LLC lifted its position in shares of Altria Group by 4.6% during the second quarter. Bernardo Wealth Planning LLC now owns 3,379 shares of the company’s stock valued at $243,000 after purchasing an additional 149 shares in the last quarter. Old Peak Finance LLC lifted its position in shares of Altria Group by 1.3% during the 2nd quarter. Old Peak Finance LLC now owns 11,920 shares of the company’s stock worth $858,000 after buying an additional 151 shares in the last quarter. Finally, Joel Isaacson & Co. LLC boosted its position in Altria Group by 0.7% in the second quarter. Joel Isaacson & Co. LLC now owns 23,324 shares of the company’s stock worth $1,678,000 after purchasing an additional 152 shares during the last quarter. Institutional investors own 57.41% of the company’s stock.

More Altria Group News Here are the key news stories impacting Altria Group this week:

Positive Sentiment: Altria outperformed a weak market in the latest session, indicating continued demand for its relatively defensive, income-oriented profile. Altria Ascends While Market Falls Positive Sentiment: Several dividend-focused articles identify Altria as an attractive high-yield stock because of its approximately 6% yield, established tobacco brands, pricing power and strong cash flow. One screening article specifically emphasizes that Altria’s payout is supported by cash rather than merely a high headline yield. High-Yield Dividend Stocks With Cash to Spare Positive Sentiment: Altria’s dividend and cash-generation profile compare favorably with other income stocks, supporting its appeal to investors seeking reliable current income despite modest growth prospects. Altria’s 6.2% Dividend Yield Neutral Sentiment: Altria is scheduled to report third-quarter results later this month. Analysts expect single-digit earnings growth, making the report a near-term test of whether pricing and cost controls can offset declining cigarette volumes. Altria Earnings Preview Negative Sentiment: Bearish analysis argues that Altria’s rally has moved ahead of underlying earnings growth. The view is that recent EPS support has come partly from tax benefits and discount brands rather than stronger core Marlboro performance; a cited fair value of $63.80 implies downside from current levels. Altria Rally Ahead of Earnings Growth Negative Sentiment: Structural risks remain: fewer consumers smoke, and Altria must successfully expand smoke-free products to sustain earnings. This creates concern that the high dividend yield may reflect limited long-term growth as well as income value. Altria Strong Sell Analysis Wall Street Analyst Weigh In MO has been the topic of a number of research analyst reports. Wall Street Zen cut shares of Altria Group from a “buy” rating to a “hold” rating in a research note on Sunday, June 21st. UBS Group lifted their target price on Altria Group from $76.00 to $79.00 and gave the company a “buy” rating in a report on Tuesday, July 7th. Weiss Ratings restated a “buy (b)” rating on shares of Altria Group in a research report on Monday. Barclays decreased their price objective on shares of Altria Group from $64.00 to $58.00 and set an “underweight” rating on the stock in a research report on Tuesday, August 11th. Finally, BTIG Research assumed coverage on Altria Group in a research note on Tuesday, July 21st. They issued a “neutral” rating on the stock. Five equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Altria Group currently has a consensus rating of “Hold” and an average price target of $70.11. Check Out Our Latest Research Report on MO

Insider Transactions at Altria Group In other news, Director Kathryn McQuade acquired 1,500 shares of the firm’s stock in a transaction on Wednesday, September 9th. The stock was acquired at an average price of $67.62 per share, for a total transaction of $101,430.00. Following the completion of the acquisition, the director owned 114,929 shares in the company, valued at $7,771,498.98. This trade represents a 1.32% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.10% of the company’s stock.

Altria Group Trading Up 2.1% Shares of NYSE:MO opened at $73.05 on Thursday. The company has a market cap of $121.98 billion, a price-to-earnings ratio of 15.41, a price-to-earnings-growth ratio of 2.55 and a beta of 0.42. Altria Group, Inc. has a 12 month low of $54.70 and a 12 month high of $77.06. The company has a 50-day moving average price of $68.38 and a 200-day moving average price of $69.53.

Altria Group (NYSE:MO – Get Free Report) last announced its earnings results on Thursday, July 30th. The company reported $1.48 EPS for the quarter, missing analysts’ consensus estimates of $1.50 by ($0.02). Altria Group had a net margin of 33.99% and a negative return on equity of 315.29%. The business had revenue of $5.36 billion for the quarter, compared to the consensus estimate of $5.35 billion. During the same quarter in the prior year, the company earned $1.44 EPS. Altria Group’s revenue was up 1.2% compared to the same quarter last year. Altria Group has set its FY 2026 guidance at 5.610-5.720 EPS. As a group, research analysts forecast that Altria Group, Inc. will post 5.67 EPS for the current fiscal year.

Altria Group Increases Dividend The company also recently announced a quarterly dividend, which was paid on Friday, October 9th. Shareholders of record on Tuesday, September 15th were issued a dividend of $1.11 per share. This is a positive change from Altria Group’s previous quarterly dividend of $1.06. The ex-dividend date was Tuesday, September 15th. This represents a $4.44 dividend on an annualized basis and a dividend yield of 6.1%. Altria Group’s dividend payout ratio (DPR) is currently 93.67%.

About Altria Group (Free Report)

Altria Group, Inc is a U.S.-based holding company focused primarily on tobacco and nicotine products. Through its operating companies, Altria manufactures and markets cigarettes, cigars, smokeless tobacco, oral nicotine products and electronic cigarettes. Its portfolio includes well-known brands such as Marlboro cigarettes, Copenhagen and Skoal smokeless tobacco, Black & Mild cigars, NJOY e-cigarettes and on! nicotine pouches.

Altria’s principal businesses include Philip Morris USA, the largest U.S.

Read More Five stocks we like better than Altria Group Tesla Wants to Make Its Own Chips—What Could Go Wrong? IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver? PBF Energy’s Stunning Rally Faces a Critical Test Citi Stock Falls Despite Earnings Beat: What Investors Need to Know

Receive News & Ratings for Altria Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Altria Group and related companies with MarketBeat.com's FREE daily email newsletter.

First Citizens Bank & Trust Co. lifted its stake in shares of The Goldman Sachs Group, Inc. (NYSE:GS – Free Report) by 76.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,976 shares of the investment management company’s stock after purchasing an additional 2,588 shares during the period. First Citizens Bank & Trust Co.’s holdings in The Goldman Sachs Group were worth $5,381,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. BlackRock Inc. bought a new stake in The Goldman Sachs Group in the second quarter valued at approximately $24,172,123,000. Bank of America Corp DE acquired a new stake in shares of The Goldman Sachs Group in the second quarter valued at approximately $6,756,772,000. Orange County Employees Retirement System bought a new position in shares of The Goldman Sachs Group during the 2nd quarter worth approximately $69,537,544,000. Corient Private Wealth LLC boosted its stake in shares of The Goldman Sachs Group by 1,657.7% during the 4th quarter. Corient Private Wealth LLC now owns 2,596,487 shares of the investment management company’s stock worth $2,282,312,000 after acquiring an additional 2,448,767 shares during the period. Finally, Bank of New York Mellon Corp acquired a new position in shares of The Goldman Sachs Group during the 2nd quarter worth approximately $2,560,028,000. Institutional investors own 71.21% of the company’s stock.

The Goldman Sachs Group Trading Down 1.7% GS stock opened at $877.07 on Thursday. The company has a debt-to-equity ratio of 2.82, a quick ratio of 0.63 and a current ratio of 1.10. The company’s 50-day simple moving average is $980.74 and its 200 day simple moving average is $989.49. The Goldman Sachs Group, Inc. has a 52 week low of $740.01 and a 52 week high of $1,153.99. The company has a market capitalization of $255.38 billion, a PE ratio of 12.82, a price-to-earnings-growth ratio of 0.98 and a beta of 1.29.

The Goldman Sachs Group (NYSE:GS – Get Free Report) last issued its quarterly earnings data on Tuesday, October 13th. The investment management company reported $17.01 earnings per share for the quarter, topping the consensus estimate of $12.86 by $4.15. The business had revenue of $18.68 billion during the quarter, compared to analysts’ expectations of $16.83 billion. The Goldman Sachs Group had a net margin of 15.77% and a return on equity of 19.55%. The business’s revenue was up 23.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $12.25 EPS. As a group, sell-side analysts anticipate that The Goldman Sachs Group, Inc. will post 67.48 earnings per share for the current year. The Goldman Sachs Group Dividend Announcement The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 30th. Shareholders of record on Wednesday, December 2nd will be issued a $5.00 dividend. The ex-dividend date of this dividend is Wednesday, December 2nd. This represents a $20.00 annualized dividend and a yield of 2.3%. The Goldman Sachs Group’s payout ratio is currently 30.87%.

Analyst Ratings Changes A number of research firms recently weighed in on GS. Wells Fargo & Company dropped their price target on The Goldman Sachs Group from $1,325.00 to $1,175.00 and set an “overweight” rating on the stock in a research note on Friday, September 25th. Oppenheimer lowered shares of The Goldman Sachs Group from a “market perform” rating to an “underperform” rating in a research note on Tuesday, June 30th. Jefferies Financial Group set a $1,299.00 price target on shares of The Goldman Sachs Group in a report on Wednesday, July 15th. Loop Capital set a $1,050.00 price target on shares of The Goldman Sachs Group in a report on Thursday, October 8th. Finally, Barclays raised their price objective on shares of The Goldman Sachs Group from $1,048.00 to $1,245.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, thirteen have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $1,050.55.

Check Out Our Latest Report on GS

The Goldman Sachs Group News Summary Here are the key news stories impacting The Goldman Sachs Group this week:

Positive Sentiment: Goldman Sachs reported third-quarter EPS of $17.01 versus the $12.86 consensus estimate, while revenue rose 23% year over year to $18.68 billion, exceeding expectations. Net income increased 29% to $5.29 billion. Reuters earnings report Positive Sentiment: Equities revenue surged 72% to $6.44 billion, investment-banking fees climbed 21%, and wealth-management assets reached a record $2.1 trillion. The board also declared a $5-per-share quarterly dividend, and Goldman returned $4.49 billion to shareholders during the quarter. Zacks earnings analysis Positive Sentiment: CEO David Solomon described Goldman’s business as “big, durable and diverse,” said the underlying economy remains strong, and reiterated that no leadership succession transition is underway. Jim Cramer also identified GS as his favorite bank stock following the results. CNBC interview with David Solomon Neutral Sentiment: Citigroup cut its GS price target to $1,000 from $1,050 and retained a Neutral rating, while RBC lowered its target to $1,010 from $1,220 and assigned a Sector Perform rating. The targets still imply upside, but the reductions signal more cautious valuation expectations. Benzinga analyst target changes Negative Sentiment: Hotter-than-expected inflation data pressured financial stocks and raised concerns that interest rates could remain elevated. Solomon warned that abrupt rate moves could create headwinds, while analysts cited late-cycle risks and Goldman’s already-premium valuation. Benzinga analysis of GS weakness Negative Sentiment: A Treasury review found that major U.S. banks’ reputation-risk policies could allow political or social considerations to influence access to banking services. Although no company-specific action was announced, the findings could increase regulatory and reputational scrutiny for Goldman Sachs. CNBC Treasury review (Free Report)

The Goldman Sachs Group, Inc is a global financial services company headquartered in New York City. Founded in 1869, the firm provides services to corporations, financial institutions, governments, individuals and other clients through its investment banking, markets, asset management and wealth management businesses.

Goldman Sachs advises clients on mergers and acquisitions, financing and other strategic transactions, and facilitates trading in equities, fixed income, currencies and commodities.

Further Reading Five stocks we like better than The Goldman Sachs Group Tesla Wants to Make Its Own Chips—What Could Go Wrong? IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver? PBF Energy’s Stunning Rally Faces a Critical Test Citi Stock Falls Despite Earnings Beat: What Investors Need to Know Want to see what other hedge funds are holding GS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Goldman Sachs Group, Inc. (NYSE:GS – Free Report).

Receive News & Ratings for The Goldman Sachs Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Goldman Sachs Group and related companies with MarketBeat.com's FREE daily email newsletter.

First Citizens Bank & Trust Co. bought a new stake in Linde PLC (NASDAQ:LIN – Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 7,334 shares of the basic materials company’s stock, valued at approximately $3,481,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. State Street Corp boosted its position in shares of Linde by 3.7% in the second quarter. State Street Corp now owns 20,344,181 shares of the basic materials company’s stock worth $10,558,016,000 after acquiring an additional 719,052 shares during the last quarter. Invesco Ltd. increased its holdings in shares of Linde by 26.0% during the 4th quarter. Invesco Ltd. now owns 5,402,317 shares of the basic materials company’s stock worth $2,303,494,000 after buying an additional 1,114,751 shares during the last quarter. Amundi raised its position in shares of Linde by 13.4% in the 1st quarter. Amundi now owns 3,162,409 shares of the basic materials company’s stock worth $1,567,796,000 after buying an additional 373,012 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Linde by 2.4% in the first quarter. Dimensional Fund Advisors LP now owns 2,740,541 shares of the basic materials company’s stock valued at $1,358,712,000 after acquiring an additional 64,078 shares during the last quarter. Finally, Royal Bank of Canada increased its position in Linde by 18.0% during the 4th quarter. Royal Bank of Canada now owns 2,250,532 shares of the basic materials company’s stock worth $959,605,000 after purchasing an additional 343,161 shares in the last quarter. 82.80% of the stock is owned by hedge funds and other institutional investors.

Linde Price Performance Shares of LIN opened at $492.70 on Thursday. The company has a market capitalization of $227.12 billion, a price-to-earnings ratio of 31.83, a P/E/G ratio of 2.87 and a beta of 0.71. Linde PLC has a fifty-two week low of $387.78 and a fifty-two week high of $548.20. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.88 and a quick ratio of 0.75. The business’s 50-day moving average is $478.29 and its 200-day moving average is $498.13.

Linde (NASDAQ:LIN – Get Free Report) last issued its quarterly earnings data on Friday, July 31st. The basic materials company reported $4.50 earnings per share for the quarter, topping analysts’ consensus estimates of $4.49 by $0.01. Linde had a net margin of 20.43% and a return on equity of 20.09%. The business had revenue of $9.29 billion during the quarter, compared to analysts’ expectations of $9.02 billion. During the same period in the previous year, the company earned $4.09 earnings per share. Linde’s revenue for the quarter was up 9.3% on a year-over-year basis. Linde has set its FY 2026 guidance at 17.700-17.900 EPS and its Q3 2026 guidance at 4.450-4.550 EPS. Equities research analysts expect that Linde PLC will post 17.86 EPS for the current fiscal year. Linde Announces Dividend The company also recently announced a quarterly dividend, which was paid on Thursday, September 17th. Stockholders of record on Thursday, September 3rd were issued a $1.60 dividend. The ex-dividend date of this dividend was Thursday, September 3rd. This represents a $6.40 annualized dividend and a dividend yield of 1.3%. Linde’s dividend payout ratio is presently 41.34%.

Analyst Upgrades and Downgrades A number of equities analysts have commented on LIN shares. The Goldman Sachs Group set a $580.00 price objective on shares of Linde and gave the stock a “buy” rating in a report on Monday, August 10th. Weiss Ratings raised shares of Linde from a “buy (b-)” rating to a “buy (b)” rating in a research report on Tuesday, July 21st. Bank of America raised their target price on shares of Linde from $532.00 to $550.00 and gave the stock a “neutral” rating in a report on Friday, July 17th. Argus cut their target price on shares of Linde from $563.00 to $538.00 and set a “buy” rating on the stock in a report on Monday, September 28th. Finally, Barclays assumed coverage on Linde in a research note on Monday. They issued an “overweight” rating and a $577.00 target price for the company. Two investment analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $547.29.

Check Out Our Latest Analysis on LIN

Linde Company Profile (Free Report)

Linde plc (NASDAQ:LIN) is a global industrial gases and engineering company that supplies gases, related equipment and process technologies to customers in healthcare, manufacturing, chemicals, energy, food and beverage, electronics, and other industries. Its products include oxygen, nitrogen, argon, hydrogen, helium, carbon dioxide and specialty gases.

The company provides gases through on-site production facilities, pipelines, bulk deliveries and packaged cylinders. It also designs and builds industrial gas plants and offers technologies and services for applications such as hydrogen production, carbon capture, clean energy, semiconductor manufacturing, metal fabrication and medical care.

Linde traces its history to 1879, when German engineer Carl von Linde developed refrigeration and gas-related technologies.

Featured Stories Five stocks we like better than Linde Tesla Wants to Make Its Own Chips—What Could Go Wrong? IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver? PBF Energy’s Stunning Rally Faces a Critical Test Citi Stock Falls Despite Earnings Beat: What Investors Need to Know Want to see what other hedge funds are holding LIN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Linde PLC (NASDAQ:LIN – Free Report).

Receive News & Ratings for Linde Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Linde and related companies with MarketBeat.com's FREE daily email newsletter.

First Citizens Bank & Trust Co. grew its position in NextEra Energy, Inc. (NYSE:NEE – Free Report) by 53.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 72,268 shares of the utilities provider’s stock after purchasing an additional 25,180 shares during the period. First Citizens Bank & Trust Co.’s holdings in NextEra Energy were worth $5,474,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Focus Financial Network Inc. increased its holdings in shares of NextEra Energy by 4.9% during the 3rd quarter. Focus Financial Network Inc. now owns 13,248 shares of the utilities provider’s stock valued at $1,003,000 after purchasing an additional 619 shares in the last quarter. Roberts Wealth Advisors LLC raised its position in shares of NextEra Energy by 2.1% in the third quarter. Roberts Wealth Advisors LLC now owns 78,492 shares of the utilities provider’s stock worth $5,945,000 after acquiring an additional 1,642 shares during the period. ASK Capital Investment Managers LLC purchased a new stake in shares of NextEra Energy during the 3rd quarter worth about $3,023,000. Cohen Capital Management Inc. boosted its stake in shares of NextEra Energy by 1.2% during the 3rd quarter. Cohen Capital Management Inc. now owns 105,426 shares of the utilities provider’s stock worth $7,985,000 after acquiring an additional 1,210 shares in the last quarter. Finally, Signal Advisors Wealth LLC grew its position in shares of NextEra Energy by 4.5% during the 3rd quarter. Signal Advisors Wealth LLC now owns 42,844 shares of the utilities provider’s stock valued at $3,245,000 after acquiring an additional 1,845 shares during the period. Institutional investors and hedge funds own 78.72% of the company’s stock.

NEE stock opened at $78.41 on Thursday. NextEra Energy, Inc. has a one year low of $74.41 and a one year high of $98.75. The firm has a market cap of $163.57 billion, a PE ratio of 17.62, a PEG ratio of 2.41 and a beta of 0.64. The firm’s 50 day moving average price is $81.34 and its 200-day moving average price is $86.76. The company has a debt-to-equity ratio of 1.45, a quick ratio of 0.44 and a current ratio of 0.53.

NextEra Energy (NYSE:NEE – Get Free Report) last issued its quarterly earnings data on Friday, July 24th. The utilities provider reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. NextEra Energy had a return on equity of 12.28% and a net margin of 32.40%. The company had revenue of $7.53 billion during the quarter, compared to analyst estimates of $8.11 billion. During the same period in the prior year, the business posted $1.05 earnings per share. The firm’s revenue for the quarter was up 12.4% compared to the same quarter last year. NextEra Energy has set its FY 2026 guidance at 3.920-4.020 EPS. On average, equities research analysts anticipate that NextEra Energy, Inc. will post 4.03 EPS for the current year. NextEra Energy Dividend Announcement The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Friday, August 28th were given a dividend of $0.6232 per share. This represents a $2.49 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date of this dividend was Friday, August 28th. NextEra Energy’s dividend payout ratio (DPR) is presently 55.96%.

Analyst Ratings Changes Several brokerages recently weighed in on NEE. BMO Capital Markets lifted their price target on NextEra Energy from $94.00 to $96.00 and gave the company an “outperform” rating in a research note on Monday, July 27th. Erste Group Bank cut NextEra Energy from a “buy” rating to a “hold” rating in a research report on Thursday, June 25th. Seaport Research Partners reaffirmed a “sell” rating and set a $56.00 target price (up from $55.00) on shares of NextEra Energy in a research note on Friday, October 2nd. Mizuho decreased their target price on NextEra Energy from $95.00 to $80.00 and set a “neutral” rating on the stock in a research report on Tuesday, October 6th. Finally, Morgan Stanley set a $110.00 price target on shares of NextEra Energy and gave the company an “overweight” rating in a research note on Wednesday. Eighteen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $99.65.

Read Our Latest Stock Report on NEE

Key Headlines Impacting NextEra Energy Here are the key news stories impacting NextEra Energy this week:

Positive Sentiment: NextEra’s strong earnings-surprise history and favorable combination of analyst estimate trends and business expectations have increased the possibility of another quarterly earnings beat. Analysts expect earnings of roughly $1.23 per share for the third quarter, while the company’s full-year 2026 guidance is $3.92-$4.02 per share. Will NextEra Beat Estimates Again in Its Next Earnings Report? Positive Sentiment: Wells Fargo reiterated a Buy rating and a $108 price target, implying substantial upside from recent trading levels. The bullish view reflects NextEra’s earnings growth potential and long-term utility and clean-energy development pipeline. Wells Fargo Keeps Buy Rating on NextEra Energy Positive Sentiment: A proposed shareholder-litigation settlement would provide NextEra with a $15.5 million insurance-funded payment and introduce governance reforms. Investors may view the agreement as reducing legal uncertainty and improving oversight, although the reforms could keep governance issues in focus. Governance Settlement and Earnings Expectations Positive Sentiment: NextEra’s long record of dividend increases and expected earnings growth support the case for continued dividend growth, which may appeal to income-focused investors. NextEra’s Dividend Growth Outlook Neutral Sentiment: Investors are awaiting the company’s upcoming earnings report. A beat could support the shares, but guidance and management commentary on growth, financing and Florida Power & Light regulation will likely determine the lasting market reaction. Negative Sentiment: Morgan Stanley identified NextEra among clean-tech companies whose valuations could be affected by higher interest rates. Rising rates can increase financing costs and reduce the appeal of utility and renewable-energy cash flows. Clean-Tech Valuation Impact from Higher Rates Negative Sentiment: KeyCorp lowered its 2026 EPS estimate to $3.96 from $4.02 and trimmed forecasts for 2027, 2029 and 2030. Although it raised its fourth-quarter 2026 estimate to $0.49, the broader reductions indicate some concern about longer-term earnings momentum. NextEra Energy Company Profile (Free Report)

NextEra Energy, Inc is an electric power and energy infrastructure company headquartered in Juno Beach, Florida. Through its principal subsidiary, Florida Power & Light Company (FPL), the company generates, transmits, distributes and sells electricity to customers across Florida. FPL serves residential, commercial and industrial customers and operates a diverse generation portfolio that includes natural gas, solar, nuclear and other resources.

NextEra Energy’s other major business, NextEra Energy Resources, develops, owns and operates energy projects in the United States and Canada.

Further Reading Five stocks we like better than NextEra Energy Tesla Wants to Make Its Own Chips—What Could Go Wrong? IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver? PBF Energy’s Stunning Rally Faces a Critical Test Citi Stock Falls Despite Earnings Beat: What Investors Need to Know Want to see what other hedge funds are holding NEE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NextEra Energy, Inc. (NYSE:NEE – Free Report).

Receive News & Ratings for NextEra Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextEra Energy and related companies with MarketBeat.com's FREE daily email newsletter.